AU2001241600B2 - Leafy cotyledon1 genes and their uses - Google Patents

Description

WO 01/64022 PCT/US01/05454 LEAFY COTYLEDON1 GENES AND THEIR USES CROSS REFERENCE TO RELATED APPLICATIONS The present application is a Continuation-In-Part of United States Patent Application Serial Number (USSN) 09/193,931, filed November 17, 1998, which is a CIP of USSN 09/103,478, filed June 24, 1998, which is a CIP of USSN 09/026,221, filed February 19, 1998, which is a CIP of USSN 08/804,534, filed February 21, 1997. Each of the aforementioned applications is explicitly incorporated herein by reference in their entirety and for all purposes.

FIELD OF THE INVENTION The present invention is directed to plant genetic engineering. In particular, it relates to new embryo-specific genes useful in improving agronomically important plants.

BACKGROUND OF THE INVENTION Embryogenesis in higher plants is a critical stage of the plant life cycle in which the primary organs are established. Embryo development can be separated into two main phases: the early phase in which the primary body organization of the embryo is laid down and the late phase which involves maturation, desiccation and dormancy. In the early phase, the symmetry of the embryo changes from radial to bilateral, giving rise to a hypocotyl with a shoot meristem surrounded by the two cotyledonary primordia at the apical pole and a root meristem at the basal pole. In the late phase, during maturation the embryo achieves its maximum size and the seed accumulates storage proteins and lipids. Maturation is ended by the desiccation stage in which the seed water content decreases rapidly and the embryo passes into metabolic quiescent state. Dormancy ends with seed germination, and development continues from the shoot and the root meristem regions.

The precise regulatory mechanisms which control cell and organ differentiation during the initial phase of embryogenesis are largely unknown. The plant hormone abscisic acid (ABA) is thought to play a role during late embryogenesis, mainly in the maturation stage by inhibiting germination during embryogenesis (Black. M. (1991). In Abscisic Acid: Physiology and Biochemistry, W. J. Davies and H. G. Jones, eds. (Oxford: Bios Scientific Publishers Ltd.), pp. 99-124) Koornneef, and Karssen, C. M. (1994). In Arabidopsis, E. M. Meyerowitz and C. R. Sommerville, eds. (Cold Spring Harbor: Cold Spring Harbor Laboratory Press), pp. 313-334). Mutations which effect seed development WO 01/64022 PCT/US01/05454 and are ABA insensitive have been identified in Arabidopsis and maize. The ABA insensitive (abi3) mutant of Arabidopsis and the viviparousl (vpl) mutant of maize are detected mainly during late emhryogenesis (McCarty et al., (1989) Plant Ceil 1, 523-532 and Parcy et al., (1994) Plant Cell 6, 1567-1582). Both the VP1 gene and the AB13 genes have been isolated and were found to share conserved regions (Giraudat, J. (1995) Current Opinion in Cell Biology 7:232-238 and McCarty, D. R. (1995). Annu. Rev. Plant Physiol.

Plant Mol. Biol. 46:71-93). The VP1 gene has been shown to function as a transcription activator (McCarty. et al., (1991) Cell 66:895-906). It has been suggested that ABI3 has a similar function.

Another class of embryo defective mutants involves three genes: LEAFY COTYLEDON1 and 2 (LEC1, LEC2) and FUSCA3 (FUS3). These genes are thought to play a central role in late embryogenesis (Baumlein, et al. (1994) Plant J. 6:379-387: Meinke.

D. W. (1992) Science 258:1647-1650 Meinke et al.. Plani Cell 6:1049-1064: West et al., (1994) Plant Cell 6:1731-1745). Like the abi3 muilant. leafy cotyledon-lype mutants are defective in late embryogenesis. In these mutants, seed morphology is altered, the shoot meristcm is activated early, storage proteins arc lacking and developing cotyledons accumulate anthocyanin. As with abi3 mutants, they are desiccation intolerant and therefore die during late embryogenesis. Nevertheless, the immature mutants embryos can be rescued to give rise to mature and fertile plants. However, unlike abi3 when the immature mutants germinate they exhibit trichomes on the adaxial surface of the cotyledon. Trichomes are normally present only on leaves, stems and sepals, not cotyledons. Therefore, it is thought that the leafy cotyledon type genes have a role in specifying cotyledon identity during embryo development.

Among the above mutants, the led mutant exhibits the most extreme phenotype during embryogenesis. For example, the maturation and postgermination programs are active simultaneously in the led mutant (West el al., 1994), suggesting a critical role for LEC1 in gene regulation during late embryogenesis.

In spite of the recent progress in defining the genetic control of embryo development, further progress is required in the identification and analysis of genes expressed specifically in the embryo and seed. Characterization of such genes would allow for the genetic engineering plants with a variety of desirable traits. For instance, modulation of the expression of genes which control embryo development may be used to alter traits such as accumulation of storage proteins in leaves and cotyledons. Alternatively, promoters from embryo or seed-specific genes can be used to direct expression of desirable heterologous genes to the embryo or seed. The present invention addresses these and other needs.

SUMMARY OF THE INVENTION According to a first aspect there is provided an isolated nucleic acid molecule comprising a polynucleotide which encodes a polypeptide comprising a CCAAT binding factor domain, wherein said polypeptide modulates embryo development in plants, and wherein said polypeptide has at least 85% sequence identity to SEQ ID NO:22.

According to a second aspect there is provided an expression cassette comprising a heterologous promoter operably linked to a nucleic acid molecule comprising a 0o polynucleotide which encodes a polypeptide comprising a CCAAT binding factor domain, wherein said polypeptide modulates embryo development in plants, and wherein said polypeptide has at least 85% sequence identity to SEQ ID NO:20 or SEQ ID NO:22.

According to a third aspect there is provided an expression vector comprising the expression cassette of the second aspect.

According to a fourth aspect there is provided a host cell comprising the expression cassette of the second aspect.

According to a fifth aspect there is provided a transgenic plant cell or transgenic plant comprising the expression cassette of the second aspect.

According to a sixth aspect there is provided a method of modulating embryo development in a plant, the method comprising introducing into the plant a heterologous polynucleotide operably linked to a promoter, wherein the polynucleotide: encodes a polypeptide which comprises a CCAAT binding factor domain and which modulates embryo development in plants; and (ii) encodes a polypeptide that has at least 85% sequence identity to SEQ ID NO:20 or SEQ ID NO:22.

According to a seventh aspect there is provided a method of inducing ectopic development of embryonic tissue in a plant, the method comprising introducing into the plant a heterologous polynucleotide operably linked to a promoter, wherein the polynucleotide: encodes a polypeptide which comprises a CCAAT binding factor domain and which modulates embryo development in plants; and (ii) encodes a polypeptide that has at least 85% sequence identity to SEQ ID or SEQ ID NO:22.

According to an eighth aspect there is provided an expression cassette comprising a promoter linked to a polynucleotide fragment of SEQ ID NO:19 or SEQ ID NO:21, [I:\DAYLIB\LIBVV102816.doc:sxc wherein the fragment is at least 30 nucleotides in length, and wherein when the expression cassette is introduced into a plant, LEC1 expression is inhibited.

According to a ninth aspect there is provided a method of modulating embryo development in a plant, the method comprising introducing into the plant an expression cassette, the expression cassette as described in aspect eight.

According to a tenth aspect there is provided a method of introducing an ectopic development of embryonic tissue in a plant, the method comprising introducing into the plant an expression cassette as described in the eight aspect.

The present invention is based, in part, on the isolation and characterization of LEC1 genes. The invention provides isolated nucleic acid molecules comprising a LEC1 polynucleotide sequence which is at least 68% identical to the B domain of SEQ ID NO:2.

The invention also provides expression cassettes comprising a promoter operably linked to a heterologous polynucleotide sequence or complement thereof, encoding a LEC1 polypeptide comprising a sequence which is at least 68% identical to the B domain of SEQ ID NO:2. In some embodiments, the polynucleotide sequence is heterologous to any element in the expression cassette. In a preferred embodiment, the B domain comprises a polypeptide between about amino acid residue 28 and amino acid residue 117 of SEQ ID NO:2. In a more preferred embodiment, the B domain comprises a polypeptide sequence with an amino terminus at amino acid residues 28-35 and a carboxy terminus at amino acid residues 103-117 of SEQ ID NO:2.

In particularly preferred embodiments, the LEC1 polypeptide is shown in SEQ ID or 22. Such LEC1 polypeptides can be encoded by the polynucleotide sequences shown in SEQ ID NO:19 or SEQ ID NO:21, respectively. In another embodiment, the LEC1 polypeptide is a fusion between two or more LEC1 polypeptides of polypeptide subsequences.

The expression cassette comprises a promoter operably linked to the LEC1 polynucleotide or its complement. For example, the promoter can be a constitutive promoter. Alternatively, the promoter can be a promoter from a LEC1 gene. For instance, the LEC1 promoter can be from about nucleotide 1 to about nucleotide 1998 of SEQ ID NO:3. In one embodiment, the heterologous polynucleotide can be linked to the promoter in the antisense orientation. In another embodiment, the promoter is SEQ ID NO:23. The promoter can further comprise SEQ ID NO:24.

In another embodiment, the invention provides an expression cassette comprising a promoter operably linked to a heterologous polynucleotide sequence, or complement [I:\DAYLIB\LIBVV]02816.doc:sxc thereof, encoding a LEC1 polypeptide comprising a subsequence at least 90% identical to the A or C domain of a LEC1 polypeptide. The polynucleotide sequence can be heterologous to any element in the expression cassette. Such expression cassettes can encode fusions of two or more LEC1 polypeptides or polypeptide subsequences.

[I:\DAYLIB\LIBVV]02816.doc:sxc WO 01/64022 PCT/US01/05454 The invention also provides for an expression cassette for the expression of heterologous polypeptides in a plant. The expression cassette comprises a LEC1 promoter operably linked to a heterologous polynucleotide. In some embodiments, the LEC 1 promoter is at least 70% identical to SEQ ID NO:23. In some embodiments, the expression cassette promoter comprises a promoter at least 70% identical to SEQ ID NO:24. Preferably. the promoter comprises the sequence displayed in SEQ ID NO:24.

The invention also provides an isolated nucleic acid or complement thereof, encoding a LEC1 polypeptide comprising a subsequence at least 6 8 identical to the B domain of SEQ ID NO:2, with the proviso that the nucleic acid is not clone MNJ7. In a preferred embodiment, the B domain comprises a polypeptide sequence with an amino terminus at amino acids 28-35 and a carboxy terminus at amino acids 103-117 of SEQ ID NO:2. In another embodiment, the LECI polypeptide is shown in SEQ ID NO: 20 or SEQ ID NO:22. Such LECI polypeptides can be encoded by the polynucleotide sequences shown in SEQ ID NO:19 or SEQ ID NO:21, respectively. In another embodiment, the LECI polypeptide is a fusion between two or more LEC 1 polypeptides of polypeptide subsequences.

The isolated nucleic acid can further compromise a promoter operably linked to the LEC1-encoding nucleic acid. The promoter can be a constitutive promoter.

Alternatively, the promoter can be a promoter from a LEC1 gene. For instance, the LEC1 promoter can be from about nucleotide 1 to about nucleotide 1998 of SEQ ID NO:3. In one embodiment, the heterologous polynucleotide can be linked to the promoter in the antisense orientation.

The invention provides a host cell comprising expression cassettes or nucleic acids of the invention. Thus, in one embodiment, the host cells of the invention comprise an expression cassette comprising a promoter operably linked to a heterologous a polynucleotide sequence, or complement thereof, encoding a LEC1 polypeptide with a subsequence at least 68% identical to the B domain of SEQ ID NO:2. In other embodiments, the host cell of the invention comprises an expression cassette comprising a promoter operably linked to a heterologous polynucleotide sequence or complement thereof, encoding a LEC 1 polypeptide with a subsequence at least 90% identical to the A or C domain of a LEC 1 poiypeptide.

Other embodiments include hosts cells comprising an expression cassette comprising a promoter at least 70% identical to SEQ ID NO:23 or an isolated nucleic acid comprising a subsequence at least 68% identical to the B domain of SEQ ID NO:2, so long as the nucleic acid is not clone MNJ7.

WO 01/64022 PCT/US01/05454 The invention also provides isolated polypeptides comprising amino acid sequences at least 68% identical to the B domain of SEQ ID NO:2 and capable of exhibiting at least one of the biological activities of the polypeptides encoded in SEQ ID NO: 1 SEQ ID NO:19 or SEQ ID NO:21, or a fragment thereof. Antibodies capable of binding the abovedescribed polypeptide are also provided.

Also provided are methods of introducing an isolated nucleic acid into a host cell. The method comprises providing an expression cassette of nucleic acid of the invention as described herein and contacting the expression cassette or nucleic acid with the host cell under conditions that permit insertion of the nucleic acid into the host cell.

The invention also provides transgenic plant cells or plants comprising an expression cassette comprising a promoter operably linked to a heterologous polynucleotide sequence, or complement thereof, encoding a LEC 1 polypeptide comprising a sequence which is at least 68% identical to the B domain of SEQ ID NO:2. In a preferred embodiment, the LEC1 polypeptide is shown in SEQ ID NO: 20 or SEQ ID NO:22. Such LEC1 polypeptides can be encoded by the polynucleotide sequences shown in SEQ ID NO:19 or SEQ ID NO:21, respectively. The invention also provides plants that are regenerated from the plant cells discussed above.

The expression cassette promoter can be a constitutive promoter.

Alternatively, the promoter can be a promoter from a LEC1 gene. For instance, the LEC1 promoter can be from about nucleotide 1 to about nucleotide 1998 of SEQ ID NO:3. In one embodiment, the heterologous polynucleotide can be linked to the promoter in the antisense orientation. In another embodiment, the promoter is SEQ ID NO:23. The promoter can also further comprise SEQ ID NO:24.

The invention also provides an expression cassette for the expression of a heterologous polynucleotide in a plant cell, comprising a promoter polynucleotide at least identical to SEQ ID NO:23, wherein the promoter polynucleotide is operably linked to a heterologous polynucleotide. In one embodiment, the promoter polynucleotide is SEQ ID NO:23. The promoter can also further comprise a polynucleotide at least 70% identical to SEQ ID NO:24. In a preferred embodiment, the promoter comprises SEQ ID NO:24.

The invention also provides methods of modulating transcription comprising.

introducing into the plant an expression cassette containing a plant promoter operably linked to a heterologous LEC1 polynucleotide, the heterologous LECI polynucleotide encoding a LEC1 polypeptide comprising a subsequence at least 68% identical to the B domain of SEQ ID NO:2 and detecting a plant with modulated transcription. Embodiments of these methods WO 01/64022 PCTiUS01/05454 include where the LEC1 polynucleotide is SEQ ID NO:2. SEQ ID NO:20 or SEQ ID NO:22.

In other embodiments, the LEC1 polypeptides are encoded by SEQ ID NO:1. SEQ ID NO:19 or SEQ ID NO:21. Preferred embodiments of the invention include the method where transcription modulation results in induction of embyonic characteristics in a plant. In an alternative embodiment, transcription modulation results in induction of seed development.

The invention also provides a method of detecting a nucleic acid in a sample. The method comprises providing an isolated LECl nucleic acid molecule comprising a polynucleotide sequence, or complement thereof, encoding a LEC 1 polypeptide with a subsequence at least 68% identical to the B domain of SEQ ID NO:2., contacting the isolated nucleic acid molecule with a sample under conditions which permit a comparison of the sequence of the isolated nucleic acid molecule with the sequence of DNA in the sample; and analyzing the result of the comparison. In some embodiments, the isolated nucleic acid molecule and the sample arc contacted under conditions which permit the formation of a duplex between complementary nucleic acid sequences.

Definitions The phrase "nucleic acid" refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5' to the 3' end. Nucleic acids may also include modified nucleotides that permit correct read through by a polymerase and do not alter expression of a polypeptide encoded by that nucleic acid.

The phrase "polynucleotide sequence" or "nucleic acid sequence" includes both the sense and antisense strands of a nucleic acid as either individual single strands or in the duplex. It includes, but is not limited to. self-replicating plasmids, chromosomal sequences, and infectious polymers of DNA or RNA.

The phrase "nucleic acid sequence encoding" refers to a nucleic acid which directs the expression of a specific protein or peptide. The nucleic acid sequences include both the DNA strand sequence that is transcribed into RNA and the RNA sequence that is translated into protein. The nucleic acid sequences include both the full length nucleic acid sequences as well as non-full length sequences derived from the full length sequences. It should be further understood that the sequence includes the degenerate codons of the native sequence or sequences which may be introduced to provide codon preference in a specific host cell.

The term "promoter" refers to a region or sequence determinants located upstream or downstream from the start of transcription and which are involved in recognition and binding of RNA polymerase and other proteins to initiate transcription. A "plant WO 01/64022 PCT(US01/05454 promoter" is a promoter capable of initiating transcription in plant cells. Such promoters need not be of plant origin, for example, promoters derived from plant viruses, such as the promoter, can be used in the present invention.

The term "plant" includes whole plants, shoot vegetative organs/structures leaves, stems and tubers), roots, flowers and floral organs/structures (e.g bracts, sepals, petals, stamens. carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat) and fruit (the mature ovary), plant tissue vascular tissue, ground tissue, and the like) and cells guard cells, egg cells, trichomes and the like), and progeny of same. The class of plants that can be used in the method of the invention is generally as broad as the class of higher and lower plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms. ferns, and multicellular algae. It includes plants of a variety of ploidy levels, including aneuploid.

polyploid. diploid, haploid and hcmizygous.

A polynucleotide sequence is "heterologous to" an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form. For example, a promoter operably linked to a heterologous coding sequence refers to a coding sequence from a species different from that from which the promoter was derived, or, if from the same species, a coding sequence which is different from any naturally occurring allelic variants. As defined here, a modified LEC 1 coding sequence which is heterologous to an operably linked LEC1 promoter does not include the T- DNA insertional mutants as described in West et al., The Plant Cell 6:1731-1745 (1994).

A polynucleotide "exogenous to" an individual plant is a polynucleotide which is introduced into the plant by any means other than by a sexual cross. Examples of means by which this can be accomplished are described below, and include Agrobacteriummediated transformation, biolistic methods, electroporation, in planta techniques, and the like. Such a plant containing the exogenous nucleic acid is referred to here as an Rl generation transgenic plant. Transgenic plants which arise from sexual cross or by selfing are descendants of such a plant.

As used herein an "embryo-specific gene" or "seed specific gene" is a gene that is preferentially expressed during embryo development in a plant. For purposes of this disclosure, embryo development begins with the first cell divisions in the zygote and continues through the late phase of embryo development (characterized by maturation.

desiccation, dormancy), and ends with the production of a mature and desiccated seed.

Embryo-specific genes can be further classified as "early phase-specific" and "late phase- 8 specific". Early phase-specific genes are those expressed in embryos up to the end of embryo morphogenesis. Late phase-specific genes are those expressed from maturation through to production of a mature and desiccated seed.

A "LEC1 polynucleotide" is a nucleic acid sequence comprising (or consisting of) a coding region of about 100 to about 900 nucleotides, sometimes from about 300 to about 630 nucleotides, which hybridizes to SEQ ID NO:1 under stringent conditions (as defined below), or which encodes a LEC1 polypeptide. LEC1 polynucleotides can also be identified by their ability to hybridize under low stringency conditions Tm -40 0

C)

to nucleic acid probes having a sequence from position 1 to 81 in SEQ ID NO:1 or from position 355 to 627 in SEQ ID NO:1.

A "promoter from a LEC1 gene" or "LEC1 promoter" will typically be about 500 to about 2000 nucleotides in length, usually from about 750 to 1500. Exemplary promoter sequences are shown as nucleotides 1-1998 of SEQ ID NO:3 or as SEQ ID NO:23. A LEC1 promoter can also be identified by its ability to direct expression in all, or 15 essentially all, proglobular embryonic cells, as well as cotyledons and axes of a late embryo.

A "LEC1 polypeptide" is a sequence of about 50 to about 210, sometimes 100 to 150, amino acid residues encoded by a LEC1 polynucleotide. A full length LEC1 :polypeptide and fragments containing a CCAAT binding factor (CBF) domain can act as 20 a subunit of a protein capable of acting as a transcription factor in plant cells. LEC1 polypeptides are often distinguished by the presence of a sequence which is required for S" binding the nucleotide sequence: CCAAT. In particular, a short region of seven residues (MPIANVI; SEQ ID NO:5) at residues 34-40 of SEQ ID NO:2 shows a high degree of similarity to a region that has been shown to required for binding the CCAAT box.

Similarly, residues 61-72 of SEQ ID NO:2 (IQECVSEYISFV; SEQ ID NO:6) is nearly identical to a region that contains a subunit interaction domain (Xing, et al., (1993) EMBOJ. 12:4647-4655).

As used herein, a homolog of a particular embryo-specific gene SEQ ID NO:1) is a second gene in the same plant type or in a different plant type, which has a polynucleotide sequence of at least 50 contiguous nucleotides which are substantially identical (determined as described below) to a sequence in the first gene. It is believed that, in general, homologs share a common evolutionary past.

"Increased or enhanced LEC1 activity or expression of the LEC1 gene" refers to an augmented change in LEC1 activity. Examples of such increased activity or expression include the following. LEC1 activity or expression of the LEC1 gene is increased above [L:\DAYLB\LBVV]02816.doc:sxc 8a the level of that in wild-type, non-transgenic control plants the quantity of LECI activity or [1:\DAYLIB\LIBVV]02816.doc:sxc WO 01/64022 PCT/US01/05454 expression of the LEC1 gene is increased). LEC1 activity or expression of the LEC1 gene is in an organ, tissue or cell where it is not normally detected in wild-type, non-transgenic control plants spatial distribution of LEC1 activity or expression of the L[EC gene is increased). LEC1 activity or expression is increased when LEC1 activity or expression of the LEC1 gene is present in an organ, tissue or cell for a longer period than in a wild-type, nontransgenic controls duration of LEC1 activity or expression of the LECI gene is increased).

A "polynucleotide sequence from" a particular embryo-specific gene is a subsequence or full length polynucleotide sequence of an embryo-specific gene which, when present in a transgenic plant, has the desired effect, for example, inhibiting expression of the endogenous gene driving expression of an hetcrologous polynucleotide. A full length sequence of a particular gene disclosed here may contain about 95%, usually at least about 98% of an entire sequence shown in the Sequence Listing, below.

lhe term "reproductive tissues" as used herein includes fruit, ovules. seeds.

pollen, pistols, flowers, or any embryonic tissue.

In the case of both expression oftransgenes and inhibition of endogenous genes by antisense, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical and may be "substantially identical" to a sequence of the gene from which it was derived. As explained below, these variants are specifically covered by this term.

In the case where the inserted polynucleotide sequence is transcribed and translated to produce a functional polypeptide, one of skill will recognize that because of codon degeneracy a number of polynucleotide sequences will encode the same polypeptide.

These variants are specifically covered by the term "polynucleotide sequence from" a particular embryo-specific gene, such as LEC1. In addition, the term specifically includes sequences full length sequences) substantially identical (determined as described below) with a LEC 1 gene sequence and that encode proteins that retain the function of a LEC polypeptide.

In the case of polynucleotides used to inhibit expression of an endogenous gene, the introduced sequence need not be perfectly identical to a sequence of the target endogenous gene. The introduced polynucleotide sequence will typically be at least substantially identical (as determined below) to the target endogenous sequence.

Two nucleic acid sequences or polypeptides are said to be "identical" if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the WO 01/64022 PCT/US01/05454 same when aligned for maximum correspondence as described below. The term "complementary to" is used herein to mean that the sequence is complementary to all or a portion of a reference polynucleotide sequence.

Optimal alignment of sequences for comparison may be conducted by the local homology algorithm of Smith and Waterman Add. APL. Math. 2:482 (1981), by the homology alignment algorithm of Needle man and Wunsch J Mol. Biol 48:443 (1970), by the search for similarity method of Pearson and Lipman Proc. Natl. Acad. Sci. 2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, BLAST, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group (GCG), 575 Science Dr., Madison, WI), or by inspection.

"Percentage of sequence identity" is determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.

The term "substantial identity" of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 25% sequence identity. Alternatively, percent identity can be any integer from 25% to 100%. More preferred embodiments include at least: 25%, 30%, 35%, 40%, 45%, 50%, 55%. 60%, 65%, 70%, 75%, 80%, 85%, or 99%. compared to a reference sequence using the programs described herein; preferably BLAST using standard parameters, as described below. Accordingly, LECI sequences of the invention include nucleic acid sequences that have substantial identity to SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:19 and SEQ ID NO:21. LEC1 sequences of the invention include polypeptide sequences having substantial identify to SEQ ID NO:2, SEQ ID NO:20 or SEQ ID NO:22. One of skill will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning and the like. Substantial identity of amino acid sequences for these purposes normally means sequence identity of at least 40%. Preferred percent identity of polypeptides can be any integer from 40% to 100%. More preferred embodiments include at WO 01/64022 PCT/US01/05454 least 60%, 65%, 70%, 75%, 80%, 85%. 90%, 95%, or 99%. Most preferred embodiments include 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74% and 75%. Polypeptides which are "substantially similar" share sequences as noted above except that residue positions which are not identical may differ by conservative amino acid changes. Conservative amino acid substitutions refer to the interchangeability of residues having similar side chains. For example, a group of amino acids having aliphatic side chains is glycine. alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine: a group of amino acids having amide-containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine: and a group of amino acids having sulfur-containing side chains is cysteine and methionine. Preferred conservative amino acids substitution groups arc: valine-leucine-isoleucinc, phcnylalaninc-tyrosine, lysine-arginine, alanine-valine.

aspartic acid-lulamiic acid. and asparagine-glutamine.

Another indication that nucleotide sequences are substantially identical is if two molecules hybridize to each other, or a third nucleic acid, under stringent conditions.

Stringent conditions are sequence dependent and will be different in different circumstances.

Generally, stringent conditions are selected to be about 5"C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Typically. stringent conditions will be those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 0

C.

In the present invention, mRNA encoded by embryo-specific genes of the invention can be identified in Northern blots under stringent conditions using cDNAs of the invention or fragments of at least about 100 nucleotides. For the purposes of this disclosure.

stringent conditions for such RNA-DNA hybridizations are those which include at least one wash in 0.2X SSC at 63C for 20 minutes, or equivalent conditions. Genomic DNA or cDNA comprising genes of the invention can be identified using the same cDNAs (or fragments of at least about 100 nucleotides) under stringent conditions, which for purposes of this disclosure, include at least one wash (usually 2) in 0.2X SSC at a temperature of at least about 50 0 C, usually about 55C, for 20 minutes, or equivalent conditions.

12 BRIEF DESCRIPTION OF THE DRAWINGS Figure 1A shows a schematic representation of the three domains of the LEC1 polypeptide. Figure 1B shows a comparison of the predicted amino acid sequence of the B domain encoded by LEC1 (SEQ ID NO:29) with HAP3 homologs from maize (SEQ ID NO:30), chicken (SEQ ID NO:31), lamprey (SEQ ID NO:32), Xenopus laevis (SEQ ID NO:33), human (SEQ ID NO:34), mouse (SEQ ID NO:35), rat (SEQ ID Emericella nidulans (SEQ ID NO:36), Schizosaccharomyces pombe (SEQ ID NO:37), Saccharomyces cerevisiae (SEQ ID NO:38), and Kluyveromyces lactis (SEQ ID NO:39).

The DNA-binding reaction and the subunit interaction region are indicated. Numbers indicate amino acid positions of the B domains.

DESCRIPTION OF THE PREFERRED EMBODIMENT The present invention provides new embryo-specific genes useful in genetically engineering plants. Polynucleotide sequences from the genes of the invention can be used, for instance, to direct expression of desired heterologous genes in embryos (in the case of promoter sequences) or to modulate development of embryos or embryonic characteristics on other organs by enhancing expression of the gene in a transgenic plant). In particular, the invention provides a new gene from Arabidopsis referred to here as LEC1. LEC1 encodes polypeptides which subunits of a protein which acts as a transcription factor. Thus, modulation of the expression of this gene can be used to manipulate a number of useful traits, such as increasing or decreasing storage protein content in cotyledons or leaves.

Generally, the nomenclature and the laboratory procedures in recombinant DNA technology described below are those well known and commonly employed in the art.

Standard techniques are used for cloning, DNA and RNA isolation, amplification and purification. Generally enzymatic reactions involving DNA ligase, DNA polymerase, restriction endonucleases and the like are performed according to the manufacturer's specifications. These techniques and various other techniques are generally performed according to Sambrook et al., Molecular Cloning A Laboratory Manual, 2nd. ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1989).

Isolation of nucleic acids of the invention The isolation of sequences from the genes of the invention may be accomplished by a number of techniques. For instance, oligonucleotide probes based on the sequences disclosed here can be used to identify the desired gene in a cDNA or genomic DNA library from a desired plant species. To construct genomic libraries, large segments of genomic DNA are generated by random fragmentation, e.g. using restriction [I:\DAYLB\LIBVV]02816.doc:sxc 13 endonucleases, and are ligated with vector DNA to form concatemers that can be packaged into the appropriate vector. To prepare a library of embryo-specific cDNAs, mRNA is isolated from embryos and a cDNA library that contains the gene transcripts is prepared from the mRNA.

The cDNA or genomic library can then be screened using a probe based upon the sequence of a cloned embryo-specific gene such as the polynucleotides disclosed here.

Probes may be used to hybridize with genomic DNA or cDNA sequences to isolate homologous genes in the same or different plant species.

Alternatively, the nucleic acids of interest can be amplified from nucleic acid samples using amplification techniques. For instance, polymerase chain reaction (PCR) technology to amplify the sequences of the genes directly from mRNA, from cDNA, from genomic libraries or cDNA libraries. PCR and other in vitro amplification methods may also be useful, for example, to clone nucleic acid sequences that code for proteins to be expressed, to make nucleic acids to use as probes for detecting the presence of the desired mRNA in samples, for nucleic acid sequencing, or for other purposes.

Appropriate primers and probes for identifying embryo-specific genes from plant tissues are generated from comparisons of the sequences provided herein. For a general overview of PCR see PCR Protocols: A Guide to Methods and Applications. (Innis, M, Gelfand, Sninsky, J. and White, eds.), Academic Press, San Diego (1990).

Appropriate primers for this purpose include, for instance: UP primer 5' GGA ATT CAG CAA CAA CCC AAC CCC A 3' (SEQ ID NO:7) and LP primer 5' GCT CTA GAC ATA CAA CAC TTT TCC TTA 3' (SEQ ID NO:8). Alternatively, the following primer pairs can be used: 5' ATG ACC AGC TCA GTC ATA GTA GC 3' (SEQ ID NO:9) and 5' GCC ACA CAT GGT GGT TGC TGC TG 3' (SEQ ID NO:10) or 5' GAG ATA GAG ACC GAT CGT GGT TC 3' (SEQ ID NO:11) and 5' TCA CTT ATA CTG ACC ATA ATG GTC 3' (SEQ ID NO:12). A third set of primers include: 5'-AGG ATC CAT GGA ACG TGG AGG CTT CCA T-3' (SEQ ID NO:25) and 5'-ATC TAG ATC AGT ACT TAT GTT GTT GAG TCG-3' (SEQ ID NO:26). The amplifications conditions are typically as follows. Reaction components: 10 mM Tris-HC1, pH 8.3, mM potassium chloride, 1.5 mM magnesium chloride, 0.001% gelatin, 200 microM (uM) dATP, 200 microM dCTP, 200 microM dGTP, 200 microM dTTP, 0.4 microM [I:\DAYLIB\LIBVV]02816.doc:sxc WO 01/64022 PCT/US01/05454 primers, and 100 units per ml Taq polymerase. Program: 96 C for 3 min., 30 cycles of 96 C for 45 sec., 50 C for 60 sec., 72 for 60 sec, followed by 72 C for 5 min.

Polynucleotides may also be synthesized by well-known techniques as described in the technical literature. See, Carruthers et al., Cold Spring Harbor Symp.

Quant. Biol. 47:411-418 (1982), and Adams et Am. Chem. Soc. 105:661 (1983).

Double stranded DNA fragments may then be obtained either by synthesizing the complementary strand and annealing the strands together under appropriate conditions, or by adding the complementary strand using DNA polymerase with an appropriate primer sequence.

Analysis of LECl Gene Sequences The genus of LEC1 nucleic acid sequences of the invention includes genes and gene products identified and characterized by analysis using the sequences nucleic acid sequences, including SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:19 and SEQ ID NO:21, and protein sequences, including SEQ ID NO:2. SEQ ID NO:20 and SEQ ID NO:22. LEC1 sequences of the invention include nucleic acid sequences having substantial identity to SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4. SEQ ID NO:19 and SEQ ID NO:21.

LEC1 sequences of the invention include polypeptide sequences having substantial identify to SEQ ID NO:2, SEQ ID NO:20 and SEQ ID NO:22.

LEC1 nucleic acid sequences also include fusions between two or more LEC1 genes. Different domains of different genes can be fused. LEC1 gene fusions can be linked directly or can be attached by additional amino acids that link the two of more fusion partners.

Gene fusions can be generated by basic recombinant DNA techniques as described below. Selection of gene fusions will depend on the desired phenotype caused by the gene fusion. For instance, if phenotypes associated with the A domain oi'one LEC1 protein are desired with phenotypes associated with the B domain of a second LEC 1 protein.

the a fusion of the first LECI protein's A domain to the second LEC1 's B domain would be created. The fusion can subsequently be tested in vitro or in vivo for the desired phenotypes.

Use of nucleic acids of the invention to inhibit gene expression The isolated sequences prepared as described herein, can be used to prepare expression cassettes useful in a number of techniques. For example, expression cassettes of the invention can be used to suppress endogenous LEC1 gene expression. Inhibiting expression can be useful. for instance, in weed control (by transferring an inhibitory sequence WO 01/64022 PCT/US01/05454 to a weedy species and allowing it to be transmitted through sexual crosses) or to produce fruit with small and non-viable seed.

A number of methods can be used to inhibit gene expression in plants. For instance, antisense technology can be conveniently used. To accomplish this, a nucleic acid segment from the desired gene is cloned and operably linked to a promoter such that the antisense strand of RNA will be transcribed. The expression cassette is then transformed into plants and the antisense strand of RNA is produced. In plant cells, it has been suggested that antisense RNA inhibits gene expression by preventing the accumulation of mRNA which encodes the enzyme of interest, see, Sheehy et al.. Proc. Nat. Acad. Sci. USA.

85:8805-8809 (1988), and Hiatt et al., U.S. Patent No. 4,801,340.

The antisense nucleic acid sequence transformed into plants will be substantially identical to at least a portion of the endogenous embryo-specific gene or genes to be repressed. The sequence, however, does not have to be perfectly identical to inhibit expression. The vectors of the present invention can be designed such that the inhibitory effect applies to other proteins within a family of genes exhibiting homology or substantial homology to the target gene.

For antisense suppression, the introduced sequence also need not be full length relative to either the primary transcription product or fully processed mRNA. Generally, higher homology can be used to compensate for the use of a shorter sequence. Furthermore.

the introduced sequence need not have the same intron or exon pattern, and homology of noncoding segments may be equally effective. Normally, a sequence of between about 30 or nucleotides and about full length nucleotides should be used, though a sequence of at least about 100 nucleotides is preferred, a sequence of at least about 200 nucleotides is more preferred, and a sequence of at least about 500 nucleotides is especially preferred.

Catalytic RNA molecules or ribozymes can also be used to inhibit expression of embryo-specific genes. It is possible to design ribozymes that specifically pair with virtually any target RNA and cleave the phosphodiester backbone at a specific location, thereby functionally inactivating the target RNA. In carrying out this cleavage, the ribozyme is not itself altered, and is thus capable of recycling and cleaving other molecules, making it a true enzyme. The inclusion of ribozyme scqucnccs within antisense RNAs confers RNA-cleaving activity upon them. thereby increasing the activity of the constructs.

A number of classes of ribozymes have been identified. One class of ribozymes is derived from a number of small circular RNAs that are capable of self-cleavage and replication in plants. The RNAs replicate either alone (viroid RNAs) or with a helper WO 01/64022 PCT/US01/05454 virus (satellite RNAs). Examples include RNAs from avocado sunblotch viroid and the satellite RNAs from tobacco ringspot virus, lucerne transient streak virus, velvet tobacco mottle virus, solanum nodiflorum mottle virus and subterranean clover mottle virus. The design and use of target RNA-specific ribozymes is described in Haseloff et al. Nature.

334:585-591 (1988).

Another method of suppression is sense suppression. Introduction of expression cassettes in which a nucleic acid is configured in the sense orientation with respect to the promoter has been shown to be an effective means by which to block the transcription of target genes. For an example of the use of this method to modulate expression of endogenous genes see, Napoli et al., The Plant Cell 2:279-289 (1990). and U.S. Patents Nos.

5,034.323, 5,231,020, and 5.283,184.

Generally, where inhibition of expression is desired. some transcription of the introduced sequence occurs. The effect may occur where the introduced sequence contains no coding sequence per se, but only intron or untranslated sequences homologous to sequences present in the primary transcript of the endogenous sequence. The introduced sequence generally will be substantially identical to the endogenous sequence intended to be repressed. This minimal identity will typically be greater than about 65%, but a higher identity might exert a more effective repression of expression of the endogenous sequences.

Substantially greater identity of more than about 80% is preferred, though about 95% to absolute identity would be most preferred. As with antisense regulation, the effect should apply to any other proteins within a similar family of genes exhibiting homology or substantial homology.

For sense suppression, the introduced sequence in the expression cassette, needing less than absolute identity, also need not be full length, relative to either the primary transcription product or fully processed mRNA. This may be preferred to avoid concurrent production of some plants which are overexpressers. A higher identity in a shorter than full length sequence compensates for a longer, less identical sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and identity of noncoding segments will be equally effective. Normally, a sequence of the size ranges noted above for antisense regulation is used.

One of skill in the art will recognize that using technology based on specific nucleotide sequences antisense or sense suppression technology), families of homologous genes can be suppressed with a single sense or antisense transcript. For instance, if a sense or antisense transcript is designed to have a sequence that is conserved WO 01/64022 PCT/US01/05454 among a family of genes the B domain of LEC1), then multiple members of a gene family can be suppressed. Conversely, if the goal is to only suppress one member of a homologous gene family, then the sense or antisense transcript should be targeted to sequences with the most vairance between family members. For instance, an antisense transcript identical to the A and C domains of LECl can be used to suppress LEC1 without suppressing related genes such as described in SEQ ID NO: 19 or SEQ ID NO:21.

Another means of inhibiting LECI function in a plant is by creation of dominant negative mutations. In this approach, non-functional, mutant LEC1 polypeptides, which retain the ability to interact with wild-type subunits are introduced into a plant.

Identification of residues that can be changed to create a dominant negative can be determined by published work examining interaction of different subunits of CBF homologs from different species (see, Sinha er al., (1995). Proc. Nail. Acad. Sci. USA 92:1624-1628.) Use of nucleic acids of the invention to enhance aene expression Isolated sequences prepared as described herein can also be used to prepare expression cassettes which enhance or increase endogenous LEC1 gene expression. Where overexpression of a gene is desired, the desired gene from a different species may be used to decrease potential sense suppression effects. Enhanced expression of LEC1 polynucleotides is useful, for example, to increase storage protein content in plant tissues. Such techniques may be particularly useful for improving the nutritional value of plant tissues.

Any of a number of means well known in the art can be used to increase LEC 1 activity in plants. Enhanced expression is useful, for example, to induce embyonic characteristics in plants or plant organs. Any organ can be targeted, such as shoot vegetative organs/structures leaves, stems and tubers), roots, flowers and floral organs!structures bracts, sepals, petals, stamens, carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat) and fruit. Alternatively, one or several LECI genes can be expressed constitutively using the CaMV 35S promoter).

One of skill will recognize that the polypeptides encoded by the genes of the invention, like other proteins, have different domains which perform different functions.

Thus, the gene sequences need not be full length, so long as the desired functional domain of the protein is expressed. As explained above, LECI polypeptides are related to CCAAT box-binding factor (CBF) proteins. CBFs are highly conserved family of transcription factors that regulate gene activity in eukaryotic organisms (see, Mantvani (1992) Nucl. Acids 18 Res. 20:1087-1091; Li (1992) Nucleic Acids Res. 20:1087-1091). LEC1 was found to have high similarity to a portion of the HAP3 subunit of CBF. Thus, without being bound to any particular theory or mechanism, LEC1 is likely to act as a transcriptional modulator. HAP3 is divided into three domains, an amino terminal A domain, a central B domain, and a carboxyl terminal C domain, as shown diagrammatically in Figure 1A.

Specifically, LEC1, has between about 75% and 85% sequence similarity, which is equivalent to 55% to 63% sequence identity, with the B domains of the other HAP3 homologs shown in Figure 1B; see also, Example 1, below. Figure 1B shows the amino acid sequence homology between LEC1 and other CBF homologs.

The LEC1 polypeptide also has an amino terminal A domain, a central B domain, and a carboxyl terminal C domain. The three domains of the LEC1 polypeptide are defined as follows: in SEQ ID NO:2, the A domain is located between about amino acid Sposition 1 to about position 27; the B domain is located between about amino acid position 28 to about position 117; and, the C domain is located between about position 118 to about position 208. The B domain of LEC1, L1L and Phaseolus LL are all S:closely related, whereas the A and C domains display almost no homology to each other.

The nucleotide sequence for LEC1 corresponding to each domain is displayed in SEQ ID NO:1, the A domain is located between about nucleotide position 1 to about nucleotide position 81; the B domain is located between about nucleotide position 82 to about nucleotide position 351; the C domain is located between about nucleotide position 352 to about nucleotide position 624.

One of skill in the art will recognize that the domain boundaries are approximate.

The boundaries for the domains of the LEC1 polypeptides and nucleotides can vary from 1 to 20 amino acids residues (1-60 nucleotides) from the boundaries listed above.

The DNA binding activity, and, therefore, transcription activation function, of LEC1 polypeptides is thought to be modulated by a short region of seven residues, MPIANVI (SEQ ID NO:5) (found, at residues 34-40 of SEQ ID NO:2). Thus, the polypeptides of the invention will often retain these sequences.

Modification of endogenous LEC1 genes Methods for introducing genetic mutations into plant genes and selecting plants with desired traits are well known. For instance, seeds or other plant material can be treated with a mutagenic chemical substance, according to standard techniques. Such chemical substances include, but are not limited to, the following: diethyl sulfate, ethylene [I:\DAYLB\LBVV]02816.doc:sxc WO 01/64022 PCT/US01/05454 imine, ethyl methanesulfonate and N-nitroso-N-ethylurea. Alternatively, ionizing radiation from sources such as, X-rays or gamma rays can be used.

Modified protein chains can also be readily designed utilizing various recombinant DNA techniques well known to those skilled in the art and described for instance, in Sambrook et al., supra. Hydroxylamine can also be used to introduce single base mutations into the coding region of the gene (Sikorski, et al.. (1991). Meth. Enzymol. 194: 302-318). For example, the chains can vary from the naturally occurring sequence at the primary structure level by amino acid substitutions, additions, deletions, and the like. These modifications can be used in a number of combinations to produce the final modified protein chain.

Alternatively, homologous recombination can be used to induce targeted gene modifications by specifically targeting the LEC1 gene in vivo (see, generally, Grewal and Klar, Genetics 146: 1221-1238 (1997) and Xu et al., Genes Dev. 10: 2411-2422 (1996)).

Homologous recombination has been demonstrated in plants (Puchta el al, Experienlia 277-284 (1994), Swoboda et al., EMBO J. 13: 484-489 (1994); Offringa el al.. Proc. Nall.

Acad. Sci. USA 90: 7346-7350 (1993); and Kempin et al. Nature 389:802-803 (1997)).

In applying homologous recombination technology to the genes of the invention, mutations in selected portions of an LECI gene sequences (including 5' upstream.

3' downstream, and intragenic regions) such as those disclosed here are made in vitro and then introduced into the desired plant using standard techniques. Since the efficiency of homologous recombination is known to be dependent on the vectors used, use of dicistronic gene targeting vectors as described by Mountford el al., Proc. Natl. Acad. Sci. USA 91: 4303- 4307 (1994): and Vaulont et al., Transgenic Res. 4: 247-255 (1995) are conveniently used to increase the efficiency of selecting for altered LECI gene expression in transgenic plants.

The mutated gene will interact with the target wild-type gene in such a way that homologous recombination and targeted replacement of the wild-type gene will occur in transgenic plant cells, resulting in suppression of LEC1 activity.

Alternatively, oligonucleotides composed of a contiguous stretch of RNA and DNA residues in a duplex conformation with double hairpin caps on the ends can be used.

The RNA/DNA sequence is designed to align with the sequence of the target LECI gene and to contain the desired nucleotide change. Introduction of the chimeric oligonucleotide on an extrachromosomal T-DNA plasmid results in efficient and specific LEC1 gene conversion directed by chimeric molecules in a small number of transformed plant cells. This method is WO 01/64022 PCT/US01/05454 described in Cole-Strauss el al., Science 273:1386-1389 (1996) and Yoon et al. Proc. Nail.

Acad. Sci. USA 93: 2071-2076 (1996).

Desired modified LEC1 polypeptides can be identified using assays to screen for the presence or absence of wild type LEC1 activity. Such assays can be based on the ability of the LEC1 protein to functionally complement the hap3 mutation in yeast. As noted above, it has been shown that homologs from different species functionally interact with yeast subunits of the CBF. (Sinha, et al., (1995). Proc. Natl. Acad. Sci. USA 92:1624-1628); see, also, Becker, et al., (1991). Proc. Natl. Acad. Sci. USA 88: 1968-1972). The reporter for this screen can be any of a number of standard reporter genes such as the lacZ gene encoding beta-galactosidase that is fused with the regulatory DNA sequences and promoter of the yeast CYC1 gene. This promoter is regulated by the yeast CBF.

A plasmid containing the LEC1 cDNA clone is mutagenized in vitro according to techniques well known in the art. The cDNA inserts are excised from the plasmid and inserted into the cloning site of a yeast expression vector such as pYES2 (Invitrogen). The plasmid is introduced into hap3- yeast containing a lacZ reporter that is regulated by the yeast CBF such as pLG265UPI-lacZ (Guarente, el al., (1984) Cell 36: 317-321). Transformants are then selected and a filter assay is used to test colonies for beta-galactosidase activity. After confirming the results of activity assays, immunochemical tests using a LEC1 antibody are performed on yeast lines that lack beta-galactosidase activity to identify those that produce stable LEC 1 protein but lack activity. The mutant LEC 1 genes are then cloned from the yeast and their nucleotide sequence determined to identify the nature of the lesions.

In other embodiments, the promoters derived from the LECI genes of the invention can be used to drive expression ofheterologous genes in an embryo-specific or seed-specific manner, such that desired gene products are present in the embryo, seed, or fruit. Suitable structural genes that could be used for this purpose include genes encoding proteins useful in increasing the nutritional value of seed or fruit. Examples include genes encoding enzymes involved in the biosynthesis of antioxidants such as vitamin A. vitamin C.

vitamin E and melatonin. Other suitable genes encoding proteins involved in modification ol fatty acids, or in the biosynthesis of lipids. proteins, and carbohydrates. Still other genes can be those encoding proteins involved in auxin and auxin analog biosynthesis for increasing fruit size, genes encoding pharmaceutically useful compounds, and genes encoding plant resistance products to combat fungal or other infections of the seed.

WO 01/64022 PCT/US01/05454 Typically, desired promoters are identified by analyzing the 5' sequences of a genomic clone corresponding to the embryo-specific genes described here. Sequences characteristic of promoter sequences can he used to identify the promoter. Sequences controlling eukaryotic gene expression have been extensively studied. For instance, promoter sequence elements include the TATA box consensus sequence (TATAAT), which is usually to 30 base pairs upstream of the transcription start site. In most instances the TATA box is required for accurate transcription initiation. In plants, further upstream from the TATA box, at positions -80 to -100, there is typically a promoter element with a series of adenines surrounding the trinucleotide G (or T) N G. J. Messing et al.. in Genetic Engineering in Plants, pp. 221-227 (Kosage, Meredith and Hollaender, eds. (1983)).

A number of methods are known to those of skill in the art for identifying and characterizing promoter regions in plant genomic DNA (see, Jordano, el al., Plant Cell, 1: 855-866 (1989); Bustos, el al., Plant Cell. 1:839-854 (1989): Green, el al.. EMBOJ. 7, 4035-4044 (1988); Meier. el al., Plant Cell. 3, 309-316(1991): and Zhang, e al., Plant Physiology 110: 1069-1079 (1996)).

Preparation of recombinant vectors To use isolated sequences in the above techniques, recombinant DNA vectors suitable for transformation of plant cells are prepared. Techniques for transforming a wide variety of higher plant species are well known and described in the technical and scientific literature. See, for example. Weising el al. Ann. Rev. Genet. 22:421-477 (1988). A DNA sequence coding for the desired polypeptide, for example a cDNA sequence encoding a full length protein, will preferably be combined with transcriptional and translational initiation regulatory sequences which will direct the transcription of the sequence from the gene in the intended tissues of the transformed plant.

For example, for overexpression, a plant promoter fragment may be employed which will direct expression of the gene in all tissues of a regenerated plant. Such promoters are referred to herein as "constitutive" promoters and are active under most environmental conditions and states of development or cell differentiation. Examples of constitutive promoters include the cauliflower mosaic virus (CaMV) 35S transcription initiation region.

the or promoter derived from T-DNA of Agrobacterium tumafaciens, and other transcription initiation regions from various plant genes known to those of skill.

Alternatively, the plant promoter may direct expression of the polynucleotide of the invention in a specific tissue (tissue-specific promoters) or may be otherwise under WO 01/64022 PCT/US01/05454 more precise environmental control (inducible promoters). Examples of tissue-specific promoters under developmental control include promoters that initiate transcription only in certain tissues, such as fruit, seeds, or flowers. As noted above, the promoters from the LEC genes described here are particularly useful for directing gene expression so that a desired gene product is located in embryos or seeds. Other suitable promoters include those from genes encoding storage proteins or the lipid body membrane protein, oleosin. Examples of environmental conditions that may affect transcription by inducible promoters include anaerobic conditions, elevated temperature, or the presence of light.

If proper polypeptide expression is desired, a polyadenylation region at the 3'end of the coding region should be included. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.

The vector comprising the sequences promoters or coding regions) from genes of the invention will typically comprise a marker gene which confers a selectable phenotype on plant cells. For example, the marker may encode biocide resistance, particularly antibiotic resistance, such as resistance to kanamycin, G418. bleomycin, hygromycin. or herbicide resistance, such as resistance to chlorosluforon or Basta.

LEC1 nucleic acid sequences of the invention are expressed recombinantly in plant cells to enhance and increase levels of endogenous LEC1 polypeptides. Alternatively.

antisense or other LEC1 constructs (described above) are used to suppress LEC1 levels of expression. A variety of different expression constructs, such as expression cassettes and vectors suitable for transformation of plant cells can be prepared. Techniques for transforming a wide variety of higher plant species are well known and described in the technical and scientific literature. See. Weising el al. Ann. Rev. Genet. 22:421-477 (1988). A DNA sequence coding for a LEC1 polypeptide. a cDNA sequence encoding a full length protein, can be combined with cis-acting (promoter) and trans-acting (enhancer) transcriptional regulatory sequences to direct the timing, tissue type and levels of transcription in the intended tissues of the transformed plant. Translational control elements can also be used.

The invention provides a LEC1 nucleic acid operably linked to a promoter which, in a preferred embodiment, is capable of driving the transcription of the LEC 1 coding sequence in plants. The promoter can be. derived from plant or viral sources. The promoter can be. constitutively active, inducible. or tissue specific. In construction of recombinant expression cassettes, vectors, transgenics, of the invention, a different promoters can be chosen and employed to differentially direct gene expression, in some or all tissues of a plant or animal.

Constitutive Promoters A promoter fragment can be employed which will direct expression of LEC1 nucleic acid in all transformed cells or tissues, e.g. as those of a regenerated plant. Such promoters are referred to herein as "constitutive" promoters and are active under most environmental conditions and states of development or cell differentiation. Promoters that drive expression continuously under physiological conditions are referred to as "constitutive" promoters and are active under most environmental conditions and states of development or cell differentiation. Examples of constitutive promoters include those from viruses which infect plants, such as the cauliflower mosaic virus (CaMV) transcription initiation region (see, Dagless (1997) Arch. Virol. 142:183-191); the 1'or promoter derived from T-DNA of Agrobacterium tumafaciens (see, Mengiste (1997) supra; (O'Grady (1995) Plant Mol. Biol. 29:99-108); the promoter of the tobacco mosaic virus; the promoter of Figwort mosaic virus (see, Maiti (1997) Transgenic Res. 6:143-156); actin promoters, such as the Arabidopsis actin gene promoter (see, e.g., Huang (1997) Plant Mol. Biol. 1997 33:125-139); alcohol dehydrogenase (Adh) gene promoters (see, Millar (1996) Plant Mol. Biol. 31:897-904); ACT11 from Arabidopsis (Huang et al. Plant Mol. Biol. 33:125-139 (1996)), Cat3 from Arabidopsis S' 20 (GenBank No. U43147, Zhong et al., Mol. Gen. Genet. 251:196-203 (1996)), the gene encoding stearoyl-acyl carrier protein desaturase from Brassica napus g* °•go* [I:\DAYLIB\LIBVV]02816.doc:sxc WO 01/64022 PCT/US01/05454 (Genbank No. X74782, Solocombe et al. Plant Physiol 104:1167-1176 (1994)), GPcl from maize (GenBank No. X15596, Martinez et al. J. Mol. Biol 208:551-565 (1989)), Gpc2 from maize (GenBank No. U45855, Manjunath et al.. Plant Mol. Biol. 33:97-112 (1997)), other transcription initiation regions from various plant genes known to those of skill. See also Holtorf(1995) "Comparison of different constitutive and inducible promoters for the overexpression oftransgenes in Arabidopsis thaliana," Plant MoI. Biol. 29:637-646.

Inducible Promoters Alternatively, a plant promoter may direct expression of the LEC1 nucleic acid of the invention under the influence of changing environmental conditions or developmental conditions. Examples of environmental conditions that may effect transcription by inducible promoters include anaerobic conditions, elevated temperature, drought, or the presence of light. Such promoters are referred to herein as "inducible" promoters. For example, the invention incorporates the drought-inducible promoter of maize (Busk (1997) supra); the cold. drought, and high salt inducible promoter from potato (Kirch (1997) Plant Mol. Biol. 33:897-909).

Alternatively, plant promoters which are inducible upon exposure to plant hormones, such as auxins, are used to express the nucleic acids of the invention. For example, the invention can use the auxin-response elements El promoter fragment (AuxREs) in the soybean (Glycine max (Liu (1997) Plant Physiol. 115:397-407); the auxinresponsive Arabidopsis GST6 promoter (also responsive to salicylic acid and hydrogen peroxide) (Chen (1996) Plant J. 10: 955-966): the auxin-inducible parC promoter from tobacco (Sakai (1996) 37:906-913); a plant biotin response clement (Streit (1997) Mol. Plant Microbe Interact. 10:933-937); and. the promoter responsive to the stress hormone abscisic acid (Sheen (1996) Science 274:1900-1902).

Plant promoters which are inducible upon exposure to chemicals reagents which can be applied to the plant, such as herbicides or antibiotics, are also used to express the nucleic acids of the invention. For example, the maize In2-2 promoter, activated by benzenesulfonamide herbicide safeners, can be used (De Veylder (1997) Plant Cell Physiol.

38:568-577); application of different herbicide safencrs induces distinct gene expression patterns, including expression in the root, hydathodes, and the shoot apical meristem. LEC1 coding sequence can also be under the control of. a tetracycline-inducible promoter, e.g..

as described with transgenic tobacco plants containing the Avena sativa L. (oat) arginine decarboxylase gene (Masgrau (1997) Plant J. 11:465-473); or. a salicylic acid-responsive clement (Stange (1997) Plant J. 11:1315-1324.

WO 01/64022 PCTfUS01/05454 Tissue-Specific Promoters Alternatively, the plant promoter may direct expression of the polynucleotide of the invention in a specific tissue (tissue-specific promoters). Tissue specific promoters are transcriptional control elements that are only active in particular cells or tissues at specific times during plant development, such as in vegetative tissues or reproductive tissues.

Promoters from the LEC 1 genes of the invention are particularly useful for tissue-specific direction of gene expression so that a desired gene product is generated only or preferentially in embryos or seeds, as described below.

Examples of tissue-specific promoters under developmental control include promoters that initiate transcription only (or primarily only) in certain tissues, such as vegetative tissues, roots or leaves, or reproductive tissues, such as fruit, ovules, seeds, pollen, pistols, flowers, or any embryonic tissue. Reproductive tissue-specific promoters may be, ovule-specific, embryo-specific, endosperm-specific, integument-specific, seed and seed coat-specific, pollen-specific, petal-specific, sepal-specific, or some combination thereof.

Suitable seed-specific promoters are derived from the following genes: MAC1 from maize, Sheridan (1996) Genetics 142:1009-1020; Cat3 from maize. GenBank No.

L05934. Abler (1993) Plant Mol. Biol. 22:10131-1038; vivparous-1 from Arabidopsis, Genbank No. U93215; atmycl from Arabidopsis. Urao (1996) Plant Mol. Biol. 32:571-57: Conceicao (1994) Plant 5:493-505: napA from Brassica napus. GenBank No. J02798, Josefsson (1987) JBL 26:12196-1301: the napin gene family from Brassica napus, Sjodahl (1995) Planta 197:264-271.

The ovule-specific BELl gene described in Reiser (1995) Cell 83:735-742.

GenBank No. U39944, can also be used. See also Ray (1994) Proc. Nail. Acad. Sci. USA 91:5761-5765. The egg and central cell specific FIE1 promoter is also a useful reproductive tissue-specific promoter.

Sepal and petal specific promoters are also used to express LEC1 nucleic acids in a reproductive tissue-specific manner. For example, the Arabidopsis floral homeotic gene APETALAI (AP1) encodes a putative transcription factor that is expressed in young flower primordia, and later becomes localized to sepals and petals (see, Gustafson- Brown (1994) Cell 76:131-143; Mandel (1992) Nature 360:273-277). A related promoter, for AP2.

a floral homeotic gene that is necessary for the normal development of sepals and petals in floral whorls, is also useful (see, Drews (1991) Cell 65:991-1002: Bowman (1991) Plailn Cell 3:749-758). Another useful promoter is that controlling the expression of the unusual WO 01/64022 PCT/US01/05454 floral organs (ufo) gene of Arabidopsis. whose expression is restricted to the junction between sepal and petal primordia (Bossinger (1996) Development 122:1093-1102).

A maize pollen-specific promoter has been identified in maize (Guerrero (1990) Mol. Gen. Genet. 224:161-168). Other genes specifically expressed in pollen are described, by Wakelcy (1998) Plant Mo. Biol. 37:187-192; Ficker (1998) Mol. Gen.

Genet. 257:132-142; Kulikauskas (1997) Plant Mol. Biol. 34:809-814; Treacy (1997) Plant Mol. Biol. 34:603-611.

Other suitable promoters include those from genes encoding embryonic storage proteins. For example, the gene encoding the 2S storage protein from Brassica napus.

Dasgupta (1993) Gene 133:301-302; the 2s seed storage protein gene family from Arabidopsis; the gene encoding oleosin 20kD from Brassica napus, GenBank No. M63985: the genes encoding oleosin A, Genbank No. U09118. and, oleosin B, Genbank No. U09119, from soybean: the gene encoding oleosin from Arabidopsis. Genbank No. Z17657: the gene encoding oleosin 18kD from maize. Genank No. J05212., 1ee (1994) Plant Mol. Biol 26:1981-1987; and, the gene encoding low molecular weight sulphur rich protein from soybean, Choi (1995) Mol Gen, Genet. 246:266-268, can be used. The tissue specific E8 promoter from tomato is particularly useful for directing gene expression so that a desired gene product is located in fruits.

A tomato promoter active during fruit ripening, senescence and abscission of leaves and, to a lesser extent, of flowers can be used (Blume (1997) Plant J. 12:731-746).

Other exemplary promoters include the pistol specific promoter in the potato (Solanum tuberosum SK2 gene, encoding a pistil-specific basic endochitinase (Fickcr (1997) Plant Mol. Biol. 35:425-431); the Blec4 gene from pea (Pisum sativum cv. Alaska), active in epidermal tissue of vegetative and floral shoot apices of transgenic alalf. This makes it a useful tool to target the expression of foreign genes to the epidermal layer of actively growing shoots.

A variety of promoters specifically active in vegetative tissues, such as leaves.

stems, roots and tubers, can also be used to express the LEC1 nucleic acids of the invention.

For example, promoters controlling patatin, the major storage protein of the potato tuber. can be used, see, Kim (1994) Plant Mol. Biol. 26:603-615: Martin (1997) Plant J. 11:53-62.

The ORF13 promoter from Agrobacterium rhizogenes which exhibits high activity in roots can also be used (Hansen (1997) Mol. Gen. Genet. 254:337-343. Other useful vegetative tissue-specific promoters include: the tarin promoter of the gene encoding a globulin from a major taro (Colocasia esculenta L. Schott) corm protein family, tarin (Bezerra (1995) Plant WO 01/64022 PCT/US01/05454 Mol. Biol. 28:137-144); the curculin promoter active during taro corm development (de Castro (1992) Plant Cell 4:1549-1559) and the promoter for the tobacco root-specific gene TobRB7, whose expression is localized to root meristem and immature central cylinder regions (Yamamoto (1991) Plant Cell 3:371-382).

Leaf-specific promoters, such as the ribulose biphosphate carboxylase (RBCS) promoters can be used. For example, the tomato RBCS1, RBCS2 and RBCS3A genes are expressed in leaves and light-grown seedlings, only RBCS1 and RBCS2 are expressed in developing tomato fruits (Meier (1997) FEBS Lett. 415:91-95). A ribulose bisphosphate carboxylase promoters expressed almost exclusively in mesophyll cells in leaf blades and leaf sheaths at high levels, described by Matsuoka (1994) Plant J. 6:311-319, can be used.

Another leaf-specific promoter is the light harvesting chlorophyll a/b binding protein gene promoter, see, Shiina (1997) Plant Physiol. 115:477-483; Casal (1998) Plant Physiol.

116:1533-1538. The Arabidopsis thaliana myb-related gene promoter (Atmyb5) described by Li (1996) FEBS Lett. 379:117-121. is leaf-specific. The Atmyh5 promoter is expressed in developing leaftrichomes. stipules, and epidermal cells on the margins of young rosette and cauline leaves, and in immature seeds. Atmyb5 mRNA appears between fertilization and the 16 cell stage of embryo development and persists beyond the heart stage. A leaf promoter identified in maize by Busk (1997) Plant J. 11:1285-1295, can also be used.

Another class of useful vegetative tissue-specific promoters are meristematic (root tip and shoot apex) promoters. For example, the "SHOOTMERISTEMLESS" and "SCARECROW" promoters, which are active in the developing shoot or root apical meristems, described by Di Laurenzio (1996) Cell 86:423-433; and, Long (1996) Nature 379:66-69; can be used. Another usefil promoter is that which controls the expression of 3-hydroxy-3- methylglutaryl coenzyme A reductase HMG2 gene, whose expression is restricted to meristematic and floral (secretory zone of the stigma, mature pollen grains, gynoecium vascular tissue, and fertilized ovules) tissues (see, Enjuto (1995) Plant (ell.

7:517-527). Also useful are knl-related genes from maize and other species which show meristem-specific expression, see, Granger (1996) Plant Mol. Biol. 31:373-378; Kerstetter (1994) Plant Cell 6:1877-1887: Hake (1995) Philos. Trans. R. Soc. Lond. 1 Biol.

Sci. 350:45-51. For example. the Arabidopsis thaliana KNAT1 promoter. In the shoot apex.

KNAT1 transcript is localized primarily to the shoot apical meristem: the expression of KNATI in the shoot meristem decreases during the floral transition and is restricted to the cortex of the inflorescence stem (see. Lincoln (1994) Plant Cell 6:1859-1876).

WO 01/64022 PCT/US01/05454 One of skill will recognize that a tissue-specific promoter may drive expression of operably linked sequences in tissues other than the target tissue. Thus, as used herein a tissue-specific promoter is one that drives expression preferentially in the target tissue, but may also lead to some expression in other tissues as well.

In another embodiment, a LEC 1 nucleic acid is expressed through a transposable element. This allows for constitutive, yet periodic and infrequent expression of the constitutively active polypcptidc. The invention also provides for use of tissue-specific promoters derived from viruses which can include, the tobamovirus subgenomic promoter (Kumagai (1995) Proc. Nail. Acad. Sci. USA 92:1679-1683: the rice tungro bacilliform virus (RTBV), which replicates only in phloem cells in infected rice plants, with its promoter which drives strong phloem-specific reporter gene expression: the cassava vein mosaic virus (CVMV) promoter, with highest activity in vascular elements, in leaf mesophyll cells, and in root tips (Verdaguer (1996) Plant Mol. Biol. 31:1129-1139).

Production of trans-enic plants DNA constructs of the invention may be introduced into the genome of the desired plant host by a variety of conventional techniques. For example, the DNA construct may be introduced directly into the genomic DNA of the plant cell using techniques such as electroporation and microinjection of plant cell protoplasts, or the DNA constructs can be introduced directly to plant tissue using ballistic methods, such as DNA particle bombardment. Alternatively, the DNA constructs may be combined with suitable T-DNA flanking regions and introduced into a conventional Agrobacterium tumefaciens host vector.

The virulence functions of the Agrobacterium tumefaciens host will direct the insertion of the construct and adjacent marker into the plant cell DNA when the cell is infected by the bacteria.

Microinjection techniques are known in the art and well described in the scientific and patent literature. The introduction of DNA constructs using polyethylene glycol precipitation is described in Paszkowski et al. Emnbo J 3:2717-2722 (1984).

Electroporation techniques are described in Fronmm et Proc. Natl. Acad. Sci. USA 82:5824 (1985). Ballistic transformation techniques are described in Klein et al. Nucare 327:70-73 (1987).

Agrobacterium tumefaciens-mediated transformation techniques, including disarming and use of binary vectors, are well described in the scientific literature. See, for WO 01/64022 PCT/US01/05454 example Horsch et al. Science 233:496-498 (1984), and Fraley et al. Proc. Natl. Acad. Sci.

USA 80:4803 (1983).

Transformed plant cells which are derived by any of the above transformation techniques can be cultured to regenerate a whole plant which possesses the transformed genotype and thus the desired phenotype such as seedlessness. Such regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, typically relying on a biocide and/or herbicide marker which has been introduced together with the desired nucleotide sequences. Plant regeneration from cultured protoplasts is described in Evans et al.. Protoplasts Isolation and Culture. Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts, pp. 21-73, CRC Press. Boca Raton, 1985. Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee e il Ann. Rev. of Plant Phys. 38:467-486 (1987).

The nucleic acids of the invention can be used to confer desired traits on essentially any plant. Thus, the invention has use over a broad range of plants, including species from the genera Asparagus, Atropa, Avena, Brassica, Citrus, Citrullus, Capsicum, Cucumis, Cucurbita, Daucus, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoscyamus, Lactuca, Linum, Lolium, Lycopersicon, Malus, Manihot, Majorana.

Medicago, Nicotiana, Oryza, Panieum, Pannesetum. Persea, Pisum, Pyrus, Prunus, Raphanus, Secale, Senecio, Sinapis, Solanum, Sorghum, Trigonella, Triticum, Vitis, Vigna, and, Zea.

The LEC1 genes of the invention are particularly useful in the production of transgenic plants in the genus Brassica. Examples include broccoli, cauliflower, brussel sprouts. canola, and the like.

Use and Recombinant Expression of LEC1 in Combination with other Genes The LEC1 nucleic acids of the invention can be expressed together with other structural or regulatory genes to achieve a desired effect. A cell or plant, such as a transformed cell or a transgenic plant, can be transformed, engineered or bred to co-express both LEC 1 nucleotide and/or LEC1 polypeptide, and another gene or gene product.

Alternatively, two or more LEC1 nucleic acids can be co-expressed together in the same plant or cell.

The LEC1 nucleic acids of the invention, when expressed in plant reproductive or vegetative tissue, can induce cctopic embryo morphogenesis. Thus, in one embodiment, a LEC 1 nucleic acid of the invention is expressed in a sense conformation in a WO 01/64022 PCT/US01/05454 transgenic plant to induce the expression of ectopic embryo-like structures, as discussed above. In another embodiment, LEC1 is co-expressed with a gene or nucleic acid that increases reproductive tissue mass, increases fruit size, seed mass, seed protein or seed oils. For example, co-expression of antiscnsc nucleic acid to ADC genes, such as AP2 and RAP2 genes of Arabidopsis, will dramatically increase seed mass, seed protein and seed oils; see, Jofuku. et al., WO 98/07842; Okamuro (1997) Proc. Nal. Acad. Sci. USA 94:7076-7081; Okamuro (1997) Plant Cell 9:37-47; Jofuku (1994) Plant Cell 6:1211-1225.

Thus, co-expression of a LEC1 of the invention, to induce ectopic expression ofembronic cells and tissues, together with another plant nucleic acid and/or protein, such as the seedmass enhancing antisense AP2 nucleic acid, generates a cell, tissue, or plant a transgenic plant) with increased fruit and seed mass, greater yields of embryonic storage proteins, and the like.

In another embodiment, the LEC1 nucleic acids of the invention are expressed in plant reproductive or vegetative cells and tissues which lack the ability to produce functional ADC genes, such as AP2 and RAP2 genes. The LEC 1 nucleic acid can be expressed in an ADC "knockout" transgenic plant. Alternatively, the LEC nucleic acid can be expressed in a cell, tissue or plant expressing a mutant ADC nucleic acid or gene product.

Expression of LEC1 nucleic acid in any of these non-functioning ADC models will also produce a cell, tissue or plant with increased fruit and seed mass, greater yields of embryonic storage proteins, and the like.

One of skill will recognize that after the expression cassette is stably incorporated in transgenic plants and confirmed to be operable, it can be introduced into other plants by sexual crossing. Any of a number of standard breeding techniques can be used.

depending upon the species to be crossed.

Example 1 This example describes the isolation and characterization of an exemplary LEC1 gene.

Experimental Procedures Plant Material A lecl-2 mutant was identified from a population of Arabidopsis thaliana ecotype Wassilewskija (Ws-O) lines mutagenized with T-DNA insertions as described before (West et al., 1994). The abi3-3, fus3-3 and lecl-1 mutants were generously provided by Peter McCourt, University of Toronto and David Meinke, Oklahoma State University.

Wild type plants and mutants were grown under constant light at 22°C.

Double mutants were constructed by intercrossing the mutant lines lecl-1, lecl-2, abi3-3, fus3-3, and lec2. The genotype of the double mutants was verified through backcrosses with each parental line. Double mutants were those who failed to complement both parent lines. Homozygous single and double mutants were generated 15 by germinating intact seeds or dissected mature embryos before desiccation on basal media.

Isolation and Sequence analysis of Genomic and cDNA Clones Genomic libraries of Ws-O wild type plants, lecl-1 and lecl-2 mutants were made in GEM11 vector according to the instructions of the manufacturer (Promega). Two silique-specific cDNA libraries (stages globular to heart and heart to young torpedo) were made in ZAPII vector (Stratagene).

The genomic library lecl-2 was screened using right and left T-DNA specific *.probes according to standard techniques. About 12 clones that cosegregate with the S: mutation, were isolated and purified and the entire DNAs were further labeled and used as probes to screen a southern blot containing wild type and lecl-1 genomic DNA. One clone hybridized with plant DNA and was further analyzed. A 7.1 kb XhoI fragment containing the left border and the plant sequence flanking the T-DNA was subcloned into pBluescript-KS plasmid (Stratagene) to form ML7 and sequenced using a left border specific primer (5'GCATAGATGCACTCGAAATCAGCC SEQ ID NO:13). The T- DNA organization was partially verified using southern analysis with T-DNA left and right borders and PBR322 probes. The results suggested that the other end of the T-DNA is also composed of left border. This was confirmed by generating a PCR fragment using a genomic plant DNA primer (LP primer 5'GCT CTA GAC ATA CAA CAC TTT TCC TTA SEQ ID NO:8) and a T-DNA left border specific primer (5'GCTTGGTAATAATTGTCATTAG SEQ ID NO:14) and sequencing.

[I:\DAYLIB\LIBVV]02816.doc:sxc The EcoRI insert of ML7 was used to screen a wild type genomic library. Two overlapping clones were purified and a 7.4kb EcoRI genomic fragment from the wild type DNA region was subcloned into pBluescript-KS plasmid making WT74. This fragment was sequenced (SEQ ID NO:4) and was used to screen lecl-1 genomic library and wild type silique-specific cDNA libraries. 8 clones from the lecl-1 genomic library were identified and analyzed by restriction mapping.

From these clones the exact site of the deletion in lecl-1 was mapped and sequenced by amplifying a Xbp PCR fragment using primers (H21 5' CTA AAA ACA TCT ACG GTT CA 3' (SEQ ID NO:15); H 17 5' TTT GTG GTT GAC CGT TTG GC 3' (SEQ ID NO:16)) flanking the deletion region in lecl-1 genomic DNA. Clones were isolated from both cDNA libraries and partially sequenced. The sequence of the cDNA clones and the wild type genomic clone matched exactly, confirming that both derived from the same locus. All hybridizations were performed under stringent conditions with 32P random prime probes (Stratagene).

15 Sequencing was done using the automated dideoxy chain termination method (Applied Biosystems, Foster City, CA). Data base searches were performed at the National Center for Biotechnology Information by using the BLAST network service.

Alignment of protein sequences was done using PILEUP program (Genetics Computer Group, Madison, WI).

DNA and RNA blot analysis Genomic DNA was isolated from leaves by using the CTAB-containing buffer Dellaporta, et al., (1983). Plant Mol. Biol. Reporter 1:19-21. Two micrograms of DNA was digested with different restriction endonucleases, electrophoretically separated in 1% agarose gel, and transferred to a nylon membrane (Hybond N; Amersham).

Total RNA was prepared from siliques, two days old seedlings, stems, leaves, buds and roots. Poly(A)+ RNA was purified from total RNA by oligo(dT) cellulose chromatography, and two micrograms of each Poly(A)+ RNA samples were separated in 1% denatured formaldehyde-agarose gel. Hybridizations were done under stringent conditions unless it specifies otherwise. Radioactive probes were prepared as described above.

[I:\DAYLIB\LIBVV02816.doc:sxc WO 01/64022 PCT/US01/05454 Complementation of lecl mutants A 3.4 kb Bstyl fragment of genomic DNA (SEQ ID NO: 3) containing sequences from 1.992 kb upstream of the ORF to a region 579 bp downstream from the poly A site was subcloned into the hygromycin resistant binary vector pBIB-Hyg. The LEC1 cDNA was placed under the control of the 35S promoter and the ocs polyadenylation signals by inserting a PCR fragment spanning the entire coding region into the plasmid pART7. The entire regulatory fragment was then removed by digestion with NotI and transferred into the hygromycin resistant binary vector BJ49. The binary vectors were introduced into the Agrobacterium strain GV3101, and constructions were checked by re-isolation of the plasmids and restriction enzyme mapping, or by PCR. Transformation to homozygous lecl -1 and lecl-2 mutants were done using the in planta transformation procedure (Bechtold, ct al., (1993). Comptes Rendus de 'Academie des Sciences Serie III Sciences de la Vie, 316: 1194-1199. Dry seeds from lec I mutants were selected for transformants by their ability to germinate after desiccation on plates containing 5g/ml hygrnmycin. The transformed plants were tested for the present of the transgene by PCR and by screening the siliques for the present of viable seeds.

In Situ Hybridization Experiments were performed as described previously by Dictrich et al. (1989) Plant Cell 1: 73-80. Sections were hybridized with LEC1 antisense probe. As a negative control, the LEC1 antisense probe was hybridized to seed sections of lecl mutants. In addition, a sense probe was prepared and reacted with the wild type seed sections.

Results Genetic Interaction Between Leafy Cotyledon-Type Mutants and abi3 In order to understand the genetic pathways which regulate late embryogenesis we took advantage of three Arabidopsis mutants lec2, fus3-3 and abi3-3 that cause similar defects in late embryogenesis to those of lec -1 or lecl-2. These mutants are desiccation intolerant, sometimes viviparous and have activated shoot apical meristems. The lec2 and fus3-3 mutants are sensitive to ABA and possess trichomes on their cotyledons and therefore can be categorized as leafy cotyledon-type mutants (Meinke et al.. 1994). The abi3-3 mutants belong to a different class of late embryo defective mutations that is insensitive to ABA and does not have trichomes on the cotyledons.

The two classes of mutants were crossed to lecl-1 and le 1-2 mutants to construct plants iomonioygous to both mutations. The lec and lec2 mutations interact WO 01/64022 PCT/US01/05454 synergistically, resulting in a double mutant which is arrested in a stage similar to the late heart stage, the double mutant embryo, however, is larger. The lecd or lec2 and fus3-3 double mutants did not display any epistasis and the resulting embryo had an intermediate phenotype. The lecl/abi3-3 double mutants and lec2/abi3-3 double mutants were ABA insensitive and had a lec-like phenotype. There was no different between double mutants that consist of either lee 1-1 or lee 1-2.

No epistasis was seen between the double mutants indicating that each of the above genes, the LEC-type and ABI3 genes, operate in different genetic pathways.

LEC1 Functions Early in Embryogenesis The effects of led is not limited to late embryogenesis, it also has a role in early embryogenesis. The embryos of the lecl/lec2 double mutants were arrested in the early stages of development, while the single mutants developed into mature embryos, suggesting that these genes act early during development.

Further examination of the early stages of the single and double mutations showed defects in the shape, size and cell division pattern of the mutants suspensors. The suspensor of wild type embryo consists of a single file of six to eight cells, whereas the suspensors of the mutants are often enlarged and undergo periclinal divisions. Leafy cotyledon mutants exhibit suspensor anomalies at the globular or transition stage whereas wild type and abi3 mutant do not show any abnormalities.

The number of anomalous suspensors increases as the embryos continue to develop. At the torpedo stage, the wild type suspensor cells undergo programmed cell death.

but in the mutants secondary embryos often develop from the abnormal suspensors and, when rescued, give rise to twins.

The Organization of the LEC 1 Locus in Wild Type Plants and led Mutants Two mutant alleles ofthe LEC1 gene have been reported, lecl-1 and lecl-2 (Meinke, 1992: West et al., 1994). Both mutants were derived from a population of plants mutagenized insertionally with T-DNA (Feldmann and Marks. 1987), although lecl-1 is not tagged. The lecl-2 mutant contains multiple T-DNA insertions. A specific subset of T-DNA fragments were found to be closely linked with the mutation. A genomic library of lecl-2 was screened using right and left borders T-DNA as probes. Genomic clones containing T-DNA fragments that cosegregate with the mutation were isolated and tested on Southern blots of both wild type and lecl-1 plants. Only one clone hybridized with Arabidopsis DNA and also gave polymorphic restriction fragment in lee 1-1.

WO 01/64022 PCTIUS01/05454 The lecl-1 polymorphism resulted from a small deletion, approximately 2 kb in length. Using sequences from the plant fragment flanking the T-DNA. the genomic wild type DNA clones and the lecl-1 genomic clones were isolated. An EcoRI fragment of 7.4 kb of the genomic wild type DNA that corresponded to the polymorphic restriction fragment in lecl-1 was further analyzed and sequenced. The exact site of the deletion in lec 1-1 was identified using a PCR fragment that was generated by primers, within the expected borders of the deleted fragment, and sequencing.

In the wild type genomic DNA that corresponded to the lec 1 deletion. a 626 bp ORF was identified. Southern analysis of wild type DNA and the two mutants DNA probed with the short DNA fragment of the ORF revealed that both the wild type and lecl-2 DNA contain the ORF while the lec -1 genomic DNA did not hybridize. The exact insertion site of the T-DNA in lee 1-2 mutant was determined by PCR and sequencing and it was found that the T-DNA was inserted 115 bp upstream of the ORF's translational initiation codon in the 5' region of the gene.

At the site of the T-DNA insertion a small deletion of 21 plant nucleic acids and addition of 20 unknown nucleic acids occurred. These results suggest that in lee 1-2 the T-DNA interferes with the regulation of the ORF while in le cl-1 the whole gene is deleted.

Thus, both led alleles contain DNA disruptions at the same locus. confirming the identity of the LEC locus.

The led Mutants Can Be Complement by Transformation To prove that the 7.4 kb genomic wild type fragment indeed contained the ORF of the LEC1 gene, we used a genomic fragment of 3395 bp (SEQ ID NO: 3) within that fragment to transform homozygous lecl-1 and lecl-2 plants. The clone consists of a 3395 bp BstYI restriction fragment containing the gene and the promoter region. The translation start codon (ATG) of the polypeptide is at 1999 and the stop codon is at 2625 (TGA). There are no introns in the gene.

The transformed plants were selected on hygromycin plates and were tested to contain the wild type DNA fragment by PCR analysis. Both transgenic mutants were able to produce viable progeny, that were desiccation tolerant and did not posses trichomes on their cotyledons. We concluded that the 3.4 kb fragment can complement the lec 1 mutation and since there is only one ORF in the deleted 2 kb fragment in lecl-1 we suggest that this ORF corresponds to the LEC gene.

WO 01/64022 PCT/US01/05454 The LEC1 Gene is a Member of Gene Family In order to isolate the LEC1 gene two cDNA libraries of young siliques were screened using the 7.4 kb DNA fragment as a probe. Seventeen clones were isolated and after further analysis and partial sequencing they were all found to be identical to the genomic ORF. The cDNA contains 626 bp ORF specifying 208 amino acid protein (SEQ ID NO:1 and SEQ ID NO:2).

The LEC1 cDNA was used to hybridize a DNA gel blot containing Ws-O genomic DNA digested with three different restriction enzymes. Using low stringency hybridization we found that there is at least one more gene. This confirmed our finding of two more Arabidopsis ESTs that show homology to the LEC1 gene.

The LEC1 gene is Embryo Specific The led mutants are affected mostly during embryogenesis. Rescued mutants can give rise to homozygous plants that have no obvious abnormalities other than the presence oftrichomes on their cotyledons and their production of defective progeny.

Therefore, we expected the LEC gene to have a role mainly during embryogenesis and not during vegetative growth. To test this assumption poly RNA was isolated from siliques.

seedling, roots, leaves, stems and buds of wild type plants and from siliques of lec plants.

Only one band was detected on northern blots using either the LEC 1 gene as a probe or the 7.4 kb genomic DNA fragment suggesting that there is only one gene in the genomic DNA fragment which is active transcriptionally. The transcript was detected only in siliques containing young and mature embryos and was not detected in seedlings, roots, leaves, stems and buds indicating that the LEC1 gene is indeed embryo specific. In addition, no RNA was detected in siliques of both alleles of lec mutants confirming that this ORF corresponds to the LEC1 gene.

Expression Pattern of the LEC1 Gene To study how the LEC1 gene specifies cotyledons identity. we analyzed its expression by in situ hybridization. We specifically focused on young developing embryos since the mutants abnormal suspensors phenotype indicates that the LEC 1 gene should be active very early during development.

During embryogenesis. the LEC 1 transcript was first detected in proglobular embryos. The transcript was found in all cells of the proembryo and was also found in the suspensor and the endosperm. However, from the globular stage and on it accumulates more in the outer layer of the embryo, namely the protoderm and in the outer part of the ground meristem leaving the procambium without a signal. At the torpedo stage the signal was stronger in the cotyledons and the root meristem, and was more limited to the protoderm layer. At the bent cotyledon stage the signal was present throughout the embryo and at the last stage of development when the embryo is mature and filling the whole seed we could not detect the LEC1 transcript. This might be due to sensitivity limitation and may imply that if the LEC1 transcript is expressed at that stage it is not localized in the mature embryo, but rather spread throughout the embryo.

The LEC1 gene encodes a Homolog of CCAAT binding factor Comparison of the deduced amino acid sequence of LEC1 to the GenBank reveals significant similarity to a subunit of a transcription factor, the CCAAT box binding factor (CBF). CBFs are highly conserved family of transcription factors that regulate gene activity in eukaryotic organisms Mantvani, et al., (1992) Nucl. Acids Res. 20:1087-1091.

They are hetero-oligomeric proteins that consist of between three to four non-homologous subunits. LEC1 was found to have high similarity to CBF-A subunit. This subunit has three domains; A and C which show no conservation between kingdoms and a central 15 domain, B, which is highly conserved evolutionary. Similarly the LEC1 gene is composed of three domains. The LEC1 B domain shares between 75%-85% similarity and 55%-63% identity with different B domains that are found in organisms ranging from yeast to human. Within this central domain, two highly conserved amino acid segments S*. are present. Deletion and mutagenesis analysis in the CBF-A yeast homolog hap3 protein demonstrated that a short region of seven residues (42-48) (LPIANVA; SEQ ID NO:17) is required for binding the CCAAT box, while the subunit interaction domain lies in the region between residues 69-80 (MQECVSEFISFV; SEQ ID NO:18) (Xing et al., supra).

LEC1 protein shares high homology to those regions.

DISCUSSION

The lecl mutant belongs to the leafy cotyledon class that interferes mainly with the embryo program and therefore is thought to play a central regulatory role during embryo development. It was shown before that LEC1 gene activity is required to suppress germination during the maturation stage. Therefore, we analyzed the genetic interaction of homozygous double mutants of the different members of the leafy cotyledon class and the abi3 mutant that has an important role during embryo maturation. All the five different combinations of the double mutants showed either an intermediate phenotype or an additive effect. No epistatic relationship among the four genes was found. These findings suggest that the different genes act in parallel genetic pathways. Of special interest was the double mutant lecl/lec2 that was arrested morphologically at the heart stage, but continued to grow [I:\DAYLB\LIBVV]0281 6.doc:sxc WO 01/64022 PCT/US01/05454 in that shape. This double mutant phenotype indicates that both genes LEC 1 and LEC2 are essential for early morphogenesis and their products may interact directly or indirectly in the young developing embryo.

The Role of LEC1 in Embryogenesis One of the proteins that mediate CCAAT box function, is an heteromeric protein called CBF (also called NFY or CP1). CBF is a transcription activator that regulates constitutively expressed genes, but also participates in differential activation of developmental genes Wingender, E. (1993). Gene Regulation in Eukaryotes (New York: VCH Publishers). In mammalian cells, three subunits have been identified CBF-A. CBF-B and CBF-C and all of which are required for DNA binding. In yeast, the CBF homolog HAP activates the CYC1 and other genes involved in the mitochondrial electron transport Johnson, et al., Proteins. Annu. Rev. Biochem. 58. 799-840. (1989). HAP consists of four subunits hap2, hap3, hap4 and hap5. Only hap2. 3 and 5 are required for DNA binding. CBF-A. B and C show high similarity to the yeast hap3. 2 and 5, respectively. It was also reported that mammalian CBF-A and B can be functionally interchangeable with the corresponding yeast subunits (Sinha et al., supra.).

The LEC 1 gene encodes a protein that shows more then 75% similarity to the conserved region of CBF-A. CCAAT motifs are not common in plants' promoters and their role in transcription regulation is not clear. However, maize and Brassica homologs have been identified. A search of the GcnBank revealed several Arabidopsis ESTs that show high similarity to CBF-A, B and C. Accession numbers of CBF-A (HAP3) homologs: H37368, H76589; CBF-B (HAP2) homologs: T20769: CBF-C (HAP5) homologs: T'43909. T44300.

These findings and the pleiotropic affects of LEC suggest that LEC is a member of a heteromeric complex that functions as a transcription factor.

The model suggests that LEC I acts as transcription activator to several sets of genes, which keep the embryonic program on and repress the germination process.

Defective LEC 1 expression partially shuts down the embryonic program and as a result the cotyledons lose their embryonic characteristics and the germination program is active in the embryo.

Example 2 This example demonstrates that LEC 1 is sufficient to induce embryonic pathways in transgenic plants.

WO 01/64022 PCT/US01/05454 The phenotype of lecl mutants and the gene's expression pattern indicated that LEC1 functions specifically during embryogenesis. A LEC1 cDNA clone under the control of the cauliflower mosaic virus 35 S promoter was transferred into lec 1 I mutant plants in planta using standard methods as described above.

Viable dry seeds were obtained from lec 1-1 mutants transformed with the 35S/LEC1 construct. However, the transformation efficiency was only approximately 0.6% of that obtained normally. In several experiments, half the seeds that germinated (12/23) produced seedlings with an abnormal morphology. Unlike wild type seedlings, these 35S/LEC1 seedlings possessed cotyledons that remained fleshy and that failed to expand.

Roots often did not extend or extended abnormally and sometimes greened. These seedlings occasionally produced a single pair of organs on the shoot apex at the position normally occupied by leaves. Unlike wild type leaves, these organs did not expand and did not possess trichomes. Morphologically. these leaf-like structures more closely resembled embryonic cotyledons than leaves.

The other 35S/LECl seeds that remained viable after drying produced plants that grow vegetatively. The majority of these plants flowered and produced 100% led mutant seeds. Amplification experiments confirmed that the seedlings contained the transgene, suggesting that the 35S/LEC1 gene was inactive in these T2 seeds. No vegetative abnormalities were observed in these plants with the exception that a few displayed defects in apical dominance. A few plants were male sterile and did not produce progeny. One plant that produced progeny segregated 25% mutant Lecl- seeds that, when germinated before desiccation and grown to maturity, gave rise to 100% mutant seed, as expected for a single transgene locus. The other 75% of seeds contained embryos with either a wild type phenotype or a phenotype intermediate between lec 1 mutants and wild type. Only 25% of the dry seed from this plant germinated, and all seedlings resembled the embryo-like seedlings described above. Some seedlings continued to grow and displayed a striking phenotype.

These 35S/LEC1 plants developed two types of structures on leaves. One type resembled embryonic cotyledons while the other looked like intact torpedo stage embryos. Thus.

ectopic expression of LEC induces the morphogenesis phase of embryo development in vegetative cells.

Because many 35S/LEC 1 seedlings exhibited embryonic characteristics, the seedlings were analyzed for expression of genes specifically active in embryos. Cruciferin A storage protein mRNA accumulated throughout the 35S/LEC1 seedlings, including the leaflike structures. Proteins with sizes characteristic of 12S storage protein cruciferin WO 01/64022 PCT/US01/05454 accumulated in these transgenic seedlings. Thus, 35S/LEC1 seedings displaying an embryolike phenotype accumulated embryo-specific mRNAs and proteins. LECI mRNA accumulated to a high level in these 35S/LEC1 seedlings in a pattern similar to early stage embryos but not in wild type seedlings. LEC1 is therefore sufficient to alter the fate of vegetative cells by inducing embryonic programs of development.

The ability of LEC1 to induce embryonic programs of development in vegetative cells establishes the gene as a central regulator of embryogenesis. LEC1 is sufficient to induce both the seed maturation pathway as indicated by the induction of storage protein genes in the 35S/LEC1 seedlings. The presence ofectopic embryos on leaf surfaces and cotyledons at the position of leaves also shows that LEC1 can activate the embryo morphogenesis pathway. Thus, LEC1 regulates both early and late embryonic processes.

Example 3 This example shows that LEC1 is expressed in zygotes and that the promoters of the invention can therefore be used to target expression in zygotes.

To determine precisely when the LEC1 gene becomes activated, LEC1 RNA levels were analyzed in the egg apparatus of mature female gametophytes before fertilization.

in zygotes after fertilization, and in very early stage embryos containing an apical cell and two to three suspensor cells. In situ hybridization experiments showed that LEC1 RNA was present in zygotes and early stage embryos but was not detected in female gametophytes.

These results show that the LEC 1 promoter becomes active in the zygote. The LEC 1 is therefore useful to target the expression of sense or antisense versions of regulatory genes or cytotoxic genes to zygotes and early stage embryos.

Example 4 This example shows the identification of a LEC 1 homolog from Arabidopsis designated the LEAFY COTYLEDON-LIKE gene.

A Blast search was conducted through the Arabidopsis Database (http://genome-www.stanford.edu/Arabidopsis/) using the LECI cDNA nucleotide sequence as a probe to identify homologs of the HAP3 subunit of CCAAT box binding transcription factor from Arabidopsis. The Arabidopsis BAC clone, MNJ7 (Accession Number AB025628), contains a gene, designated LEC1-Like (LIL), that displays the highest amino acid sequence identity with the LEC 1 protein of any known Arabidopsis [IAP3 gene. The 41 nucleotide and amino acid sequences of L1L are shown in SEQ ID NO:19 and SEQ ID respectively.

The Polymerase Chain Reaction (PCR) was used to amplify the LIL gene, which lacks introns. Primers designed to amplify the LIL open reading frame contained BamHI and XbaI restriction enzyme sites for cloning purposes. The forward primer, sequence is 5'-AGGATCCATGGAACGTGGAGGCTTCCAT-3' (SEQ ID NO:27) with the BamHI site underlined. The reverse primer, 3-MNJ7XBA sequence is 5'-ATCTAGATCAGTACTTATGTTGTTGAGTCG-3' (SEQ ID NO:28) with the XbaI site underlined. The PCR conditions were as follows: 30 cycles of 45 seconds at 94°C, 45 seconds at 53 0 C, and 3 minutes at 72 0 C. AmphiTaq DNA polymerase (Perkin Elmer Cetus, 761 Main Ave., Norwalk, CT 06859) was used. PCR products were cloned using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA 92008). The nucleotide sequence ic: of the cloned L1L gene was determined to confirm its identity.

Accumulation of LECJ-LIKE RNA The L1L clone was hybridized with gel blots containing 20gg of total RNA from leaves, stems, roots, seedlings, and siliques containing either proembryo to heart stage (early) embryos, heart to torpedo stage (middle) embryos, or torpedo to mature (late) embryos. LIL RNA was detected only in siliques containing all three stages of embryos.

Detection of the LIL RNA in siliques from lecl-1 mutants showed that the RNA detected was not LEC1. Thus, like LEC1, LIL accumulates specifically during embryogenesis.

"Complementation of lecl-1 Mutation by L1L The LIL clone was inserted into the LEC1 promoter/terminator cassette within the plant transformation vector BJ49. The LEC1 promoter/terminator cassette consists of 1992 bp of DNA 5' of the LEC1 translation start codon and 770 bp 3' of the LEC1 cDNA translation stop codon Lee, R.W. Kwong, and J.J. Harada, unpublished results).

The promoter and terminator are separated by a short polylinker with BglII and AvrII restriction endonuclease sites in which the LIL gene was inserted.

This construct was transferred into homozygous lecl-1 null mutants using in planta transformation procedures with Agrobacterium tumefaciens strain GV3101. Unlike lecl- 1 mutant plants whose progeny die following desiccation, plants transformed with the LIL construct produced viable seedlings. PCR amplification experiments confirmed that the viable seedlings have the lecl-1 mutation and the transgene. Seedlings morphologically [I:\DAYLIB\LIBVV]02816.doc:sxc WO 01/64022 PCT/US01/05454 resembled wild type rather than ledc mutant plants. These results show that the L1L gene complements the led mutation, suggesting overlapping functions for the two genes.

Example This example shows the identification of a LEC1 ortholog from scarlet runner bean.

Constructing an Embryo-Proper clNA Library from the Globular Embryo of Scarlet Runner Bean A cDNA library was constructed with 150 ng of total RNA isolated from embryo propers (EP) of the scarlet runner bean (SRB; Phaseolus coccinezus) that were dissected from globular-stage embryo. The SMART PCR cDNA Library Construction Kit (Clontech, cat K1051-1) was used according to a manufacturer's protocol. Briefly, first strand cDNA was synthesized from EP total RNA using SuperScript II RNase II- reverse transcriptase (Gibco/BRL, cat 18064-014) in the presence of an Sfi IB-site containing oligo-dT primer (CDSIII/3' PCR primer, Clontech) and a SMART II1 containing an Sfi IAsite primer (Clontech). Second strand was generated by polymerase chain reaction using and 3' PCR primers (Clontech). Double-stranded cDNA was digested with Sfi I restriction enzyme (New England BioLabs, cat 123S) and then size-fractionated over a CHROMA S- 400 sepharose column (Clontech). After analyzing collected fractions on a 1.1% agarose gel.

four fractions containing high amount of cDNAs in a range of 0.5 kb to 4 kb were pooled and precipitated in an ethanol/salt solution at -20 0 C overnight. A cDNA pellet was recovered by centrifugation and resuspended in 7 uL of sterile water. cDNA inserts were ligated to Sfi 1digested lambda arms (1TriplEx2, Clontech). Ligation mixtures were packaged into phage heads using Gigapack III Gold Packaging Extract (Stratagene).

Isolation of the Scarlet Runner Bean LEC1 ortholog cDNA.

The cDNA library was converted from a lambda form to a plasmid form via Crc-Lox system (in vivo excision, Clontech). Colonies were picked randomly for plasmid DNA isolation. The nucleotide sequences of cDNA clones were determined using BigDye terminator, a 5'-TriplEx sequencing primer (Clontech), and the ABI Prism 377 DNA sequencer (Perkin-Elmer Applied Biosystems). The identity of the cDNA clone was determined by BlastX and BlastN analyses.

A BlastX search revealed that a cDNA clone pPCEP 112 encoded a protein (SEQ ID NO:22) with high amino acid sequence identity to the Arabidopsis LEC1. especially in the conserved B domain. However, a BlastN result indicated that this SRB cDNA WO 01/64022 PCT/US01/05454 sequence is more similar to the Arabidopsis L1L gene at the nucleotide level. The entire sequence of the pPCEP 112 insert was determined to be 988 bp (SEQ ID NO:21).

Spatial Expression Pattern of the LECI-Like Gene in SRB Seeds To examine the spatial expression pattern of scarlet runner bean L1L gene in embryos, we carried out in situ hybridization analyses. The full length cDNA insert of pBSEP112 was used as the template for sense and antisense RNA probe synthesis. The L1L mRNA accumulated in both the embryo proper (EP) and suspensor of a 5 days after pollination embryo. In the 7 days after pollination seeds, the RNA is localized intensively in the epidermal layer of the embryo proper and moderately in every cell in both the embryo proper and suspensor. Only background signal was detected using the sense probe. In conclusion, the spatial expression pattern of SRB LEC -like gene in the globular embryo is similar to that of Arabidopsis LEC 1.

The above examples are provided to illustrate the invention but not to limit its scope. Other variants of the invention will be readily apparent to one of ordinary skill in the art and are encompassed by the appended claims. All publications, databases, Genbank sequences, patents, and patent applications cited herein are hereby incorporated by reference.

Claims (14)

1. An expression cassette comprising a heterologous promoter operably linked to a nucleic acid molecule comprising a polynucleotide which encodes a polypeptide 00 comprising a CCAAT binding factor domain, wherein said polypeptide modulates embryo development in plants, and wherein said polypeptide has at least 85% sequence identity to SEQ ID

2, The expression cassette of claim 1, wherein the polynucleotide comprises SEQ ID NO:19. c

3. The expression cassette of claim 1, wherein the polypeptide comprises SEQ ID N0:20.

4. The expression cassette of claim 1, wherein the promoter is selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue-specific promoter, and a LEC1 gene promoter.

The expression cassette of claim 1, wherein the polynucleotide is linked to the is promoter in the antisense orientation.

6. An expression vector comprising the expression cassette of claim 1.

7. A host cell comprising the expression cassette of claim 1.

8. A transgenic plant cell or transgenic plant comprising the expression cassette of claim 1.

9. The transgenic plant cell or transgenic plant of claim 8, which is a member of the genus Brassica.

A method of modulating embryo development in a plant, the method comprising introducing into the plant a heterologous polynucleotide operably linked to a promoter, wherein the polynucleotide: encodes a polypeptide which comprises a CCAAT binding factor domain and which modulates embryo development in plants; and (ii) encodes a polypeptide that has at least 85% sequence identity to SEQ ID

11. A method of inducing ectopic development of embryonic tissue in a plant, the method comprising introducing into the plant a heterologous polynucleotide operably linked to a promoter, wherein the polynucleotide: encodes a polypeptide which comprises a CCAAT binding factor domain and which modulates embryo development in plants; and (ii) encodes a polypeptide that has at least 85% sequence identity to SEQ ID

221543.2:LNB COMS ID No: SBMI-05970921 Received by IP Australia: Time 15:27 Date 2007-01-18 18, JAN. 2007 15:24 SPRUSON FERGUSON 92615486 NO. 8587 P. 10/11 0 8

12. The method of claim 10 or claim 11, wherein the polynucleotide comprises SEQ ID N0:19.

13. The method of claim 10 or claim 11, wherein the polypeptide comprises SEQ 00 ID s

14. The method of claim 10 or claim 11, wherein the heterologous polynucleotide is linked to the promoter in the antisense orientation. 0 The method of claim 10 or claim 11, wherein the promoter is selected from Sthe group consisting of a constitutive promoter, and inducible promoter, a tissue-specific c- promoter, and a LECI gene promoter. 0o 16. The method of claim 10 or claim 11, wherein the plant is a member of the o genus Brassica. S17. The method of claim 10 or claim 11, wherein the introducing comprises sexual crossing. 18. An expression cassette comprising a promoter linked to a polynucleotide 1$ fragment of SEQ ID NO0:19, wherein the fragment is at least 30 nucleotides in length, and wherein when the expression cassette is introduced into a plant, LEC1 expression is inhibited. 19. The expression cassette of claim 18, wherein the fragment is in the antisense orientation. 20. The expression cassette of claim 18, wherein the fragment is in the sense orientation. 21. A method of modulating embryo development in a plant, the method comprising introducing into the plant an expression cassette of claim 18. 22. A method of inducing ectopic development of embryonic tissue in a plant, the method comprising introducing into the plant an expression cassette of claim 18. 23. An isolated nucleic acid molecule comprising a polynucleotide which encodes a polypeptide comprising a CCAAT binding factor domain, wherein said polypeptide modulates embryo development in plants, and wherein said polypeptide has at least sequence identity to SEQ ID NO:20, substantially as herein described with reference to the accompanying example. 24. An expression cassette comprising a heterologous promoter operably linked to a nucleic acid molecule comprising a polynueleotide which encodes a polypeptide comprising a CCAAT binding factor domain, wherein said polypeptide modulates embryo development in plants, and wherein said polypeptide has at least 85% sequence 221543_2:LNB COMS ID No: SBMI-05970921 Received by IP Australia: Time 15:27 Date 2007-01-18 18. JAN, 2007 15:24 SPRUSON FERGUSON 92615486 NO. 8587 P. 11/11 46 Sidentity to SEQ ID NO:20, substantially as herein described with reference to the accompanying example. 00 Dated 17 January, 2007 SThe Regents of the University of California o Patent Attorneys for the Applicant/Nominated Person SSPRUSON FERGUSON ^l- 0 0 221543_2:LN6 COMS ID No: SBMI-05970921 Received by IP Australia: Time 15:27 Date 2007-01-18